At the moment, there are no entries available for display
As at 31 December 2023 > Bupa Arabia for Cooperative Insurance Company (A Saudi Joint Stock Company)
1. Organization and principal activities
Bupa Arabia for Cooperative Insurance Company (the “Company”) is a Saudi Joint Stock Company incorporated in the Kingdom of Saudi Arabia as per the Ministry of Commerce’s resolution number 138/K dated 24 Rabi Thani 1429H (corresponding to 1 May 2008). The Commercial Registration number of the Company is 4030178881 dated 5 Jumad Awwal 1429H (corresponding to 11 May 2008). The Registered Office of the Company is situated at:
Al-Khalediyah District,
Prince Saud Al Faisal Street,
Front of Saudi Airlines Cargo Building,
P.O. Box 23807, Jeddah 21436,
Kingdom of Saudi Arabia.
The Company is licensed to conduct insurance business in the Kingdom of Saudi Arabia under cooperative principles in accordance with Royal Decree No. M/74 dated 29 Shabaan 1428H (corresponding to 11 September 2007) pursuant to the Council of Ministers’ Resolution No 279 dated 28 Shabaan 1428H (corresponding to 10 September 2007).
The objective of the Company is to transact cooperative insurance operations and related activities in the Kingdom of Saudi Arabia in accordance with its articles of association, and applicable regulations in the Kingdom of Saudi Arabia. The Company underwrites medical insurance only.
The Board of Directors approves the distribution of the surplus from insurance operations in accordance with the Implementing Regulations issued by the Saudi Central Bank (“SAMA”), whereby the shareholders of the Company are to receive 90% of the annual surplus from insurance operations and the policyholders are to receive the remaining 10%. Any deficit arising on insurance operations is transferred to the shareholders’ operations in full. During the year, the Insurance Authority has been established by a royal decree as the insurance regulator. Previously issued regulations by SAMA will be upheld until the Insurance Authority issued updated regulations. Therefore, the accrued income liability is payable to the Insurance Authority.
The Company has the following subsidiaries:
Name of the subsidiary |
Registration number | Country of incorporation | Ownership | Principal business activity |
Bupa Arabia For Third Party Administration |
4030605585 | Saudi Arabia | 100% | Claims management services |
Horizon Medical Services Company | 4030512306 | Saudi Arabia | 100% | Healthcare services |
These consolidated financial statements comprise the Company and its subsidiaries (together referred to as the “Group”). Bupa Arabia For Third Party Administration commenced operations in July 2022 and prior to that subsidiary was dormant. Horizon Medical Services has not yet commenced operations.
2. Basis of preparation
(a) Statement of compliance
The consolidated financial statements of the Group have been prepared in accordance with International Financial Reporting Standards (IFRS) that are endorsed in the Kingdom of Saudi Arabia, and other standards and pronouncement that are endorsed by Saudi Organisation for Chartered and Professional Accountants (“SOCPA”) (“IFRS as endorsed by SOCPA”). The Group adopted IFRS 17 “Insurance Contracts” and IFRS 9 “Financial Instruments” as endorsed in Kingdom of Saudi Arabia and the resultant changes to the material accounting policies are described in Note 3 and Note 4.
The consolidated financial statements are prepared under the going concern basis and the historical cost convention, except for the measurement of investments at their fair value through profit or loss (FVTPL) and fair value through other comprehensive income (FVOCI) and provision for end-of-service benefits recorded at the present value using the projected unit credit method.
The Group’s consolidated statement of financial position is presented in order of liquidity. Except for financial assets, fixtures, furniture and equipment, right-of-use assets, intangible assets, goodwill, statutory deposit, deferred tax, accrued income on statutory deposit, provision for end-of-service benefits and accrued income payable to Insurance Authority, all other assets and liabilities are of short-term nature.
As required by the Saudi Arabian Insurance Regulations (The Implementation Regulations), the Company maintains separate books of accounts for “Insurance Operations” and “Shareholders’ Operations”. Accordingly, assets, liabilities, revenues and expenses attributable to either operation are recorded in the respective accounts. Note 35 to these consolidated financial statements provides the consolidated statement of financial position, consolidated statement of income, consolidated statement of comprehensive income and consolidated statement of cash flows of the insurance operations and shareholders operations, separately. The accounting policies adopted for the insurance and shareholders’ operations are in accordance with IFRS as endorsed by SOCPA.
During 2018, SAMA issued illustrative financial statements for the insurance sector in the Kingdom of Saudi Arabia. In preparing the financial statements in compliance with IFRS as endorsed by SOCPA, the balances and transactions of insurance operations are combined with those of shareholders’ operations. Inter-operation balances and transactions, if any, are eliminated in full. The accounting policies adopted for the insurance and shareholders’ operations are uniform for like transactions and events in similar circumstances.
(b) Functional and presentation currency
These consolidated financial statements are expressed in Saudi Arabian Riyals (SAR) and all amounts are rounded off to the nearest thousand, unless otherwise indicated.
(c) Fiscal year
The Group follows a fiscal year ending on 31 December.
(d) Critical accounting judgments, estimates and assumptions
The preparation of consolidated financial statements require management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets and liabilities, income and expenses and the accompanying notes disclosures including disclosure of contingent liabilities. Actual results may differ from these estimates.
(i) Insurance Contracts
The Group issues insurance contracts that transfer insurance risk. Insurance contracts are those contracts where the insurer accepts significant insurance risk from the policyholder by agreeing to compensate the policyholder if a specified uncertain future event adversely affects the policyholder. The Group uses judgement to assess whether a contract transfers insurance risk (that is, if there is a scenario with commercial substance in which the Group has the possibility of a loss on a present value basis) and whether the accepted insurance risk is significant. In making this assessment, all substantive rights, and obligations, including those arising from law or regulation, are considered on a contract-by-contract basis.
The measurement of these insurance contracts also requires significant judgement and estimates. These significant judgement and estimates include Risk Adjustment (“RA”) and liability for incurred claims – estimate of future cash flows. Refer to note 3 for further details.
(ii) Fair value of financial instruments
The fair value for financial instruments traded in active markets at the reporting date is based on their quoted market price. Where the fair values of financial assets and financial liabilities recorded on the statement of financial position cannot be derived from active markets, they are determined using a variety of valuation techniques that include the use of mathematical models. The inputs to these models are derived from observable market data where possible, but if this is not available, judgment is required to establish fair values. Refer note 19 for details.
(iii) Going Concern
The Group’s management has made an assessment of its ability to continue as a going concern and is satisfied that it has the resources to continue in business for the foreseeable future. Furthermore, management is not aware of any material uncertainties that may cast significant doubt upon the Group’s ability to continue as a going concern. Therefore, the consolidated financial statements continue to be prepared on the going concern basis.
(iv) Impairment of Goodwill
The Group tests whether goodwill has suffered any impairment on an annual basis. For the 2023 and 2022 reporting periods, the recoverable amount of the cash-generating units (CGUs) was determined based on value-in-use calculations which require the use of assumptions. The calculations use cash flow projections based on financial budgets approved by management covering a three-year period. Cash flows beyond the three-year period are extrapolated using the estimated growth rates stated in note 5. These growth rates are consistent with forecasts included in industry reports specific to the industry in which each CGU operates.
Goodwill is initially measured at cost being the excess of the net fair value of the identifiable assets and liabilities acquired. Following initial recognition, goodwill is measured at cost less any accumulated impairment losses. Goodwill is reviewed for impairment, annually or more frequently if events or changes in circumstances indicate that the carrying value may be impaired. Impairment for goodwill is determined by assessing the recoverable amount of the cash generating unit (or a group of cash generating units) to which the goodwill is related. When the recoverable amount of the cash-generating unit (or a group of cash generating units) is less than the carrying amount of the cash generating unit (or a group of cash generating units) to which goodwill has been allocated, an impairment loss is recognised. Impairment losses relating to goodwill cannot be reversed in future periods. The recoverable amount is the greater of its value in use or fair value less cost to sell. In assessing the value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risk specific to the asset.
(e) Basis of consolidation
The consolidated financial statements include the financial statements of the Company and the financial statements of the subsidiaries, as stated in note 1. The financial statements of the subsidiary is prepared for the same reporting period as that of the Group, using consistent accounting policies. Adjustments have been made to the consolidated financial statements of the subsidiary, where necessary, to align with the Group’s consolidated financial statements.
A subsidiary is the investee that is controlled by the Group. The Group controls an investee only when it has:
- Power over the investee (i.e. existing rights that give it the current ability to direct the relevant activities of the investee);
- Exposure, or rights, to variable returns from its involvement with the investee; and
- The ability to use its power over the investee to affect amount of its returns.
Intra-group balances and any unrealized income and expenses arising from intra-group transactions, are eliminated in preparing the consolidated financial statements. Unrealized losses are eliminated in the same way as unrealized gains, but only to the extent that there is no evidence of impairment.
3. Material accounting policies
the material accounting policies applied in the preparation of these consolidated financial statements are summarised below. These policies have been consistently applied to each of the years presented except new IFRS standards, IFRIC interpretations and amendments thereof, adopted by the Group as explained below:
(a) New IFRS Standards, IFRIC interpretations and amendments thereof, adopted by the Group
Narrow scope amendments to IAS 1, Practice statement 2 and IAS 8
Amendments to IAS 12 | deferred tax related to assets and liabilities arising from a single transaction |
|
Amendments to IAS 1 | Classification of Liabilities as Current or Non-current and Amendments to IAS 1 – Non-current Liabilities with Covenants. |
|
Amendments to IAS 12 | international tax reform | pillar two model rules |
IFRS 17 | Insurance contracts | (refer 3(b)(i)) |
IFRS 9 | Financial instruments | (refer 3(b)(ii)) |
These amendments had no impact on the consolidated financial statements of the Group.
b) Material accounting policies, including key judgments and estimates
(i) IFRS 17 – accounting policies, including key judgments and estimates
IFRS 17 replaces IFRS 4 Insurance Contracts and is effective for annual periods beginning on or after 1 January 2023, with early adoption permitted. IFRS 17 establishes principles for the recognition, measurement, presentation and disclosure of insurance contracts, reinsurance contracts and investment contracts with direct participation features (“DPF”). The Group has applied the full retrospective approach to each group of insurance contracts.
The Group issues insurance contracts that transfer insurance risk. Insurance contracts are those contracts where the insurer accepts significant insurance risk from the policyholder by agreeing to compensate the policyholder if a specified uncertain future event adversely affects the policyholder. Cash flows from insurance contracts are split into Liability for Incurred Claims (“LIC”) and Liability for Remaining Coverage (“LRC”).
Unit of account and measurement model
The Group operates as a mono-line insurer, operating in the Private Medical Insurance (PMI) business. The PMI business is further divided as Corporate, SMEs and Others based on customer size. All insurance contracts within PMI line represent a portfolio of contracts. Each portfolio is further disaggregated into groups of contracts that are issued within a calendar year (annual cohorts) and are: (i) contracts that are onerous at initial recognition; (ii) contracts that at initial recognition have no significant possibility of becoming onerous subsequently; or (iii) a group of remaining contracts. These groups represent the level of aggregation at which insurance contracts are initially recognised and measured. Such groups are not subsequently reconsidered.
For each portfolio of contracts, the Group determines the appropriate level at which reasonable and supportable information is available, to assess whether these contracts are onerous at initial recognition and whether non-onerous contracts have a significant possibility of becoming onerous. This level of granularity determines sets of contracts. The Group uses judgement to determine at what level of granularity the Group has reasonable and supportable information that is sufficient to conclude that all contracts within a set are sufficiently homogeneous and will be allocated to the same group without performing an individual contract assessment.
The GMM is the default model to measure insurance contracts using updated estimates and assumptions that reflect the timing of cash flows and any uncertainty relating to insurance contracts.
The liability for remaining coverage includes:
- Fulfilment cash flows which are comprised of:
- Discounted estimates of future cash flows.; and
- A risk adjustment which is the compensation required for bearing uncertainty; and
- Contractual service margin which is the unearned profit that is recognized as services are provided.
The premium allocation approach (“PAA”) is a simplified approach for the measurement of the liability for remaining coverage, that an entity may choose to use when the premium allocation approach provides a measurement which is not materially different from that under the general measurement model or if the coverage period of each contract in the group of insurance contracts is one year or less. Under the premium allocation approach, the liability for remaining coverage is measured as the amount of premiums received net of acquisition cash flows paid, less the net amount of premiums and acquisition cash flows that have been recognized in profit or loss over the expired portion of the coverage period based on the passage of time.
The Group uses the PAA for measuring contracts with a coverage period of one year or less. The Group is adopting the PAA measurement model for the measurement of LRC for the whole PMI business. This is principally based on the eligibility test for fulfillment cash flows and that coverage period for most contracts are one year or less. Some contracts have coverage period more than one year, but passed the eligibility test.
Initial and subsequent measurement
Groups of insurance contracts issued are initially recognised from the earliest of the following:
- the beginning of the coverage period;
- the date when the first payment from the policyholder is due or actually received, if there is no due date; and
- when the Group determines that a group of contracts becomes onerous.
For insurance contracts issued, on initial recognition, the Group measures the LRC at the amount of premiums received, less any acquisition cash flows paid.
The carrying amount of a group of insurance contracts issued at the end of each reporting period is the sum of:
- the LRC; and
- the LIC, comprising the fulfillment cash flows (“FCF”) related to past service allocated to the group at the reporting date.
For insurance contracts issued, at each of the subsequent reporting dates, the LRC is:
- increased for premiums received in the period, excluding amounts that relate to premium receivables included in the LIC;
- decreased for insurance acquisition cash flows paid in the period;
- decreased for the amounts of expected premium receipts recognised as insurance revenue for the services provided in the period; and
- increased for the amortisation of insurance acquisition cash flows in the period recognised as insurance service expenses.
An insurance contract may contain one or more components that would be within the scope of another standard if they were separate contracts. IFRS 17 defines investment components as the amounts that an insurance contract requires an insurer to repay to a policyholder in all circumstances, regardless of whether an insured event has occurred. For example, an insurance contract may include an investment component or a service component (or both). The non-insurance components may need to be separated for the purposes of reporting under IFRS 17 if they are deemed to be distinct. Based on Group’s assessment, there are no investment components within insurance contracts issued by the Group.
Only contracts that individually meet the recognition criteria by the end of the reporting period are included in the groups. When contracts meet the recognition criteria in the groups after the reporting date, they are added to the groups in the reporting period in which they meet the recognition criteria, subject to the annual cohorts restriction. Composition of the groups is not reassessed in subsequent periods.
The Group holds quota share reinsurance contract that provide coverage on the PMI insurance contracts for claims incurred during an accident year and are accounted for under the PAA since the Group does not expect significant variability in the fulfilment cash flows that would affect the measurement of the liability for remaining coverage under general measurement model.
The Company recognises a group of reinsurance contracts held it has entered into from the earlier of the following:
- The beginning of the coverage period of the group of reinsurance contracts held. However, the Company delays the recognition of a group of reinsurance contracts held that provide proportionate coverage until the date any underlying insurance contract is initially recognised, if that date is later than the beginning of the coverage period of the group of reinsurance contracts held; and
- The date the Company recognises an onerous group of underlying insurance contracts if the Company entered into the related reinsurance contract held in the group of reinsurance contracts held at or before that date.
The Company adds new contracts to the group in the reporting period in which that contract meets one of the criteria set out above.
For reinsurance contracts held, on initial recognition, the Group measures the remaining coverage at the amount of ceding premiums paid, plus broker fees paid to a party other than the reinsurer and any amounts arising from the derecognition of any other relevant pre-recognition cash flows. The Group is presenting income/ expense from reinsurance as a net line item in the consolidated statement of income.
Liability for Incurred Claims “LIC”
For contracts measured under the PAA, the LIC is measured similarly to the LIC’s measurement under the GMM. The Group estimates the liability for incurred claims and expenses as the fulfillment cash flows related to incurred claims and expenses. The fulfillment cash flows are an explicit, unbiased, and probability-weighted estimate of the present value of the future cash flows, within the contract boundary of a group of contracts, that will arise as the entity fulfills its obligation under the insurance contracts, including a risk adjustment for non-financial risk. The Group presents the entire change in risk adjustment as part of insurance service results.
The Group establishes insurance claims liabilities to cover the estimated liability for the cash flows associated with incurred losses as at the consolidated statement of financial position date, including claims not yet reported (“IBNR”) and loss adjustment expenses incurred with respect to insurance contracts underwritten and reinsurance contracts placed by the Group. The ultimate cost of claims liabilities is estimated by using generally accepted standard actuarial techniques.
The main assumption underlying these techniques is that the Group’s past claims development experience can be used to project future claims development and hence ultimate claims costs. As such, these methods extrapolate the development of paid and incurred losses, average costs per claim (severity) and average number of claims (frequency) based on the observed development of earlier years and expected loss ratios. Historical claims development is analyzed by accident year, geographical area, as well as claim type. Loss ratio is the ratio of total claims incurred to total premiums earned for the portfolio.
Additional qualitative judgment is used to assess the extent to which past trends may not apply in the future (e.g., to reflect one-off occurrences, changes in external or market factors such as public attitudes to claiming, economic conditions, levels of claims inflation and legislation, as well as internal factors such as portfolio mix, policy features and claims handling procedures) to arrive at the estimated ultimate cost of claims that present the probability-weighted expected value outcome from the range of possible outcomes, taking into account all the uncertainties involved.
The Group has elected not to adjust the LRC for the effect of time value of money, as it expects the time between providing each part of the coverage and the related premium due date to be one year or less. Likewise, the Group has decided not to discount the LIC for the time value of money as most of the claims incurred are expected to be settled within a 12-month period. An insignificant portion of the LIC is expected to be carried over beyond 12 months, with an immaterial impact on LIC and statement of income. The Group will regularly monitor the time it takes in settling claims from the date they are incurred. The Group has elected the accounting policy choice to present entire insurance finance income or expense for the period in the consolidated statement of income.
Contract boundary
The Group uses the concept of contract boundary to determine what cash flows should be considered in the measurement of groups of insurance contracts.
Cash flows are within the boundary of an insurance contract if they arise from the rights and obligations that exist during the period in which the policyholder is obligated to pay premiums or the Group has a substantive obligation to provide the policyholder with insurance contract services. A substantive obligation ends when:
- the Group has the practical ability to reprice the risks of the particular policyholder or change the level of benefits so that the price fully reflects those risks; or
- both of the following criteria are satisfied:
- the Group has the practical ability to reprice the contract or a portfolio of contracts so that the price fully reflects the reassessed risk of that portfolio; and
- the pricing of premiums up to the date when risks are reassessed does not reflect the risks related to periods beyond the reassessment date.
In assessing the practical ability to reprice, risks transferred from the policyholder to the Group, such as insurance and financial risks, are considered; other risks, such as lapse or surrender and expense risk, are not included. Riders, representing add-on provisions to a basic insurance policy that provide additional benefits to the policyholder at additional cost, that are issued together with the main insurance contracts, form part of a single insurance contract with all of the cash flows within its boundary.
Cash flows outside the insurance contracts boundary relate to future insurance contracts and are recognised when those contracts meet the recognition criteria.
Insurance acquisition costs
Insurance acquisition cash flows are the costs that are directly associated with selling, underwriting and starting a group of insurance contracts (issued or expected to be issued) and that are directly attributable to a portfolio of insurance contracts. Acquisition costs fall under the insurance service expense. The Group amortises the insurance acquisition costs over the contract period.
Directly attributable expenses
Directly attributable expenses are the costs that can be fully or partially attributed to the fulfillment of the groups of insurance contracts. The Group allocates the attributable costs based on a number of drivers. Attributable costs fall under the insurance service expense. While the non-attributable costs are reported under other operating expenses.
Other operating expenses
Other operating expenses include non-attributable expenses which are administrative expenses and are not linked to insurance contracts.
Insurance revenue
The insurance revenue for the period is the amount of expected premium receipts allocated to the period. The Group allocates the expected premium receipts to each period of insurance contract services on the basis of the passage of time. The impact of seasonality is not considered material in relation to recording the insurance revenue.
Insurance revenue is adjusted to allow for policyholders’ default on future premiums. The default probability is derived from the expected loss model prescribed under IFRS 9.
Insurance service expenses
- Insurance service expenses include the following:
- incurred claims for the period.
- other incurred directly attributable expenses.
- insurance acquisition cash flows amortization.
- changes that relate to past service – changes in the FCF relating to the LIC.
- changes that relate to future service – changes in the FCF that result in onerous contract losses or reversals of those losses.
Onerous contract
The Group assumes that no contracts are onerous at initial recognition, unless facts and circumstances indicate otherwise. If facts and circumstances indicate that some contracts are onerous, an additional assessment is performed to distinguish onerous contracts from non-onerous ones. A group of contracts is onerous at initial recognition if there is a net outflow of fulfilment cash flows. As a result, a liability for the net outflow is recognized as a loss component within the liability for remaining coverage and a loss is recognized immediately in the consolidated statement of income in insurance service expense. The loss component is then amortized to the consolidated statement of income over the coverage period to offset incurred claims in insurance service expense. The loss component is measured on a gross basis but may be mitigated by a loss recovery component if the contracts are covered by reinsurance.
Risk adjustment for non-financial risk
The risk adjustment for non-financial risk is applied to the present value of the estimated future cash flows, and it reflects the compensation that the Group requires for bearing the uncertainty about the amount and timing of the cash flows from non-financial risk as the Group fulfils insurance contracts. The Group has chosen a confidence level based on the 75th percentile of the distribution of the claim reserves, considering the confidence level is adequate to cover sources of uncertainty about the amount and timing of the cash flows.
(ii) IFRS 9 – accounting policies, including key judgments and estimates
IFRS 9 replaces IAS 39 Financial Instruments: Recognition and Measurement and is effective for annual periods beginning on or after 1 January 2018, with early adoption permitted. However, the Group has met the relevant criteria and has applied the temporary exemption from IFRS 9 for annual periods before 1 January 2023. For transition to IFRS 9, the Group applied a retrospective approach to be in line with transition option adopted under IFRS 17 while applying the relevant practical expedients under IFRS 9.
Financial assets – Classification
On initial recognition, a financial asset is classified as measured at amortized cost, fair value through other comprehensive income (FVOCI) or fair value through profit or loss (FVTPL).
Financial assets at amortized cost
Debt Instruments:
A financial asset is measured at amortized cost if it meets both of the following conditions and is not designated as at FVTPL:
- The asset is held within a business model whose objective is achieved by collecting contractual cash flows; and
- The contractual terms of the financial asset give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding (“SPPI”).
Financial assets at FVOCI
A debt instrument is measured at FVOCI only if it meets both of the following conditions and is not designated as at FVTPL:
- the asset is held within a business model whose objective is achieved by both collecting contractual cash flows and selling financial assets; and
- the contractual terms of the financial asset give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.
FVOCI debt instruments are subsequently measured at fair value with gains and losses arising due to changes in fair value recognized in Other Comprehensive Income (OCI). Interest income and foreign exchange gains and losses are recognized in the statement of income.
For an equity investment, the Group may irrecoverably elect to present subsequent changes in fair value in OCI. This election is made on an instrument-by- instrument basis on initial recognition.
Financial assets at FVTPL
All other financial assets are classified measured at FVTPL. In addition, on initial recognition, the Group may irrevocably designate a financial asset that otherwise meets the requirements to be measured at amortized cost or at FVOCI or at FVTPL if doing so eliminates or significantly reduces an accounting mismatch that would otherwise arise. Financial assets are not reclassified subsequent to their initial recognition, except in the period after the Group changes its business model for managing financial assets.
Business model assessment
The Group assesses the objective of a business model in which an asset is held at a portfolio level because this best reflects the way the business is managed, and information is provided to management. The information considered includes:
- the stated policies and objectives for the portfolio and the application of those policies in practice.
- whether management’s strategy focuses on earning contractual interest revenue, maintaining a particular interest rate profile, matching the duration of the financial assets to the duration of the liabilities that are funding those assets or realizing cash flows through the sale of the assets.
- how the performance of the portfolio is evaluated and reported to the Group’s management.
- the risks that affect the performance of the business model (and the financial assets held within that business model) and how those risks are managed.
- how managers of the business are compensated- e.g., whether compensation is based on the fair value of the assets managed or the contractual cash flows collected; and
- the frequency, volume, and timing of sales in prior periods, the reasons for such sales and its expectations about future sales activity. However, information about sales activity is not considered in isolation, but as part of an overall assessment of how the Group’s stated objective for managing the financial assets is achieved and how cash flows are realized.
For the purpose of the assessment of whether contractual cash flows are solely payments of principal and interest, principal is the fair value of the financial asset on initial recognition. Interest is the consideration for the time value of money, the credit and other basic lending risks associated with the principal amount outstanding during a particular period and other basic lending costs (e.g., liquidity risk and administrative costs), along with profit margin.
Financial assets – Measurement
At initial recognition, the group measures a financial asset at its fair value plus, in the case of a financial asset not at fair value through profit or loss (FVTPL), transaction costs that are directly attributable to the acquisition of the financial asset. Transaction costs of financial assets carried at FVTPL are expensed in profit or loss.
Financial assets with embedded derivatives are considered in their entirety when determining whether their cash flows are solely payment of principal and interest.
All regular-way purchases and sales of financial assets are initially recognised and derecognised on the trade date, i.e., the date that the Group becomes a party to the contractual provisions of the instrument.
Debt instruments
Subsequent measurement of debt instruments depends on the group’s business model for managing the asset and the cash flow characteristics of the asset. There are three measurement categories into which the group classifies its debt instruments:
- Amortised cost: Assets that are held for collection of contractual cash flows where those cash flows represent solely payments of principal and interest are measured at amortised cost. Interest income from these financial assets is included in finance income using the effective interest rate method. Any gain or loss arising on derecognition is recognised directly in consolidated statement of income and presented in other gains/(losses) together with foreign exchange gains and losses.
- FVOCI: Assets that are held for collection of contractual cash flows and for selling the financial assets, where the assets’ cash flows represent solely payments of principal and interest, are measured at FVOCI. Movements in the carrying amount are taken through OCI, except for the recognition of impairment gains or losses, interest income and foreign exchange gains and losses which are recognised in the consolidated statement of income. When the financial asset is derecognised, the cumulative gain or loss previously recognised in OCI is reclassified from equity to the consolidated statement of income and recognised in other gains/(losses). Interest income from these financial assets is included in finance income using the effective interest rate method. Foreign exchange gains and losses are presented in other gains/(losses) and impairment expenses are presented as separate line item in the statement of profit or loss.
- FVTPL: Assets that do not meet the criteria for amortised cost or FVOCI are measured at FVTPL. A gain or loss on a debt investment that is subsequently measured at FVTPL is recognised in the consolidated statement of income and presented net within other gains/(losses) in the period in which it arises.
Equity instruments
The Group subsequently measures all equity investments at fair value. Where the Group’s management has elected to present fair value gains and losses on equity investments in OCI, there is no subsequent reclassification of fair value gains and losses to profit or loss following the derecognition of the investments. Dividends from such investments continue to be recognised in consolidated statement of income as investment income when the group’s right to receive payments is established.
Changes in the fair value of financial assets at FVTPL are recognised in investment income in the consolidated statement of income as applicable. Impairment losses (and reversal of impairment losses) on equity investments measured at FVOCI are not reported separately from other changes in fair value.
Financial assets – Impairment
Overview of Expected Credit Loss (“ECL”) principles
The ECL allowance is based on the credit losses expected to arise over the life of the asset (the lifetime expected credit loss); unless there has been no significant increase in credit risk since origination, in which case, the allowance is based on the 12 months’ expected credit loss. Lifetime expected credit losses represent ECL that would result from all possible default events over the expected life of the financial asset whereas 12 month expected credit losses are those life expected credit losses expected to occur within 12 months of the consolidated statement of financial position date. Both lifetime ECLs and 12-month ECLs will be calculated on an individual basis depending on the nature of the underlying portfolio of financial instruments.
The Group recognizes loss allowances for ECL on the following financial instruments that are not measured at fair value:
- Financial assets that are debt instruments
- Deposits and bank balances
- Other receivables balances
No impairment loss is recognized on equity instruments.
The Group measures loss allowances at an amount equal to lifetime ECL, except for the following, for which they are measured as 12-month ECL:
- debt investment securities that are determined to have low credit risk at the reporting date; and
- other financial instruments on which credit risk has not increased significantly since their initial recognition.
The Group considers debt securities to have low credit risk when their credit risk rating is equivalent to the globally understood definition of ‘investment grade’. The measurement of ECL for other receivables is carried out using the simplified ECL impairment model and is determined by using a matrix which uses historical credit loss experience of the Group. For investment in debt securities, if the Days Past Due (‘DPD’) is 0, then investment is considered as Stage 1 and if the DPD is more than 0, investment is considered as Stage 3.
Staging of financial assets
The Group categorizes its investments portfolio classified as amortized cost and FVOCI into Stage 1, Stage 2 and Stage 3 as described below:
Credit impaired financial asset
At each reporting date, the Group assesses whether financial assets carried at amortized cost are credit impaired. A financial asset is credit-impaired when one or more events that have detrimental impact on the estimated future cash flows of the financial asset have occurred.
- Evidence that a financial asset is credit-impaired includes the following observable data:
- significant financial difficulty of the borrower or issuer;
- a breach of contract such as a default or past due event (more than 90 days);
- it is becoming probable that the borrower or issuer will enter bankruptcy or other financial reorganization; or
- the disappearance of an active market for a security because of financial difficulties.
In assessing whether an investment in sovereign debt is credit-impaired, the Group considers the following factors.
- The market’s assessment of creditworthiness as reflected in the bond yields.
- The rating agencies’ assessments of creditworthiness.
- The country’s ability to access the capital markets for new debt issuance.
- The probability of debt being restructured, resulting in holders suffering losses through voluntary or mandatory debt forgiveness.
- The international support mechanisms in place to provide the necessary support as ‘lender of last resort’ to that country, as well as the intention, reflected in public statements, of governments and agencies to use those mechanisms. This includes an assessment of the depth of those mechanisms and, irrespective of the political intent, whether there is the capacity to fulfil the required criteria.
Definition of default
In assessing whether an issuer is in default, the Group considers indicators that are:
- qualitative- e.g., breaches of covenant and non-payment on another obligation of the same issuer to the Group.
- quantitative- e.g., overdue status; and
- based on data developed internally and obtained from external sources.
Inputs into the assessment of whether a financial instrument is in default and their significance may vary over time to reflect changes in circumstances.
ECL methodology and measurement
ECL is computed based on the parameters namely Probability of Default (PD), Loss Given Default (LGD) and Exposure at Default (EAD) values. ECL is discounted by an appropriate rate to get the Present Value of ECL.
For the investment portfolio, a generalised approach is used, where assets are classified under 3 different stages based on the SICR criteria: Stage 1, Stage 2, and Stage 3 where 12-month ECL is computed for Stage 1 and lifetime ECL for Stage 2 and Stage 3. For other receivable portfolio, a simplified approach is used, for which staging is not required, based on a lifetime ECL computation.
ECL is a probability-weighted estimate of credit losses. It is measured as follows:
- financial assets that are not credit-impaired at the reporting date: as the present value of all cash shortfalls (i.e., the difference between the cash flows due to the entity in accordance with the contract and the cash flows that the Group expects to receive).
- financial assets that are credit-impaired at the reporting date: as the difference between the gross carrying amount and the present value of estimated future cash flows.
Probability of Default (‘PD’)
The probability of default is an estimate of the likelihood of default over a given time horizon.
Loss Given Default (‘LGD’)
Loss given default inputs are determined by class of financial instrument based on historical experience of loss and recovery rates for similar financial instruments and other relevant industry data.
Exposure at Default (‘EAD’)
The exposure at default is an estimate of the exposure at a future default date.
Forward looking estimate
While estimating the ECL, the Group reviews macro-economic developments occurring in the economy and market it operates in. On a periodic basis, the Group analyzes the relationship between key economic trends with the estimate of PD. The Group incorporates forward-looking information into both its assessment of whether the credit risk of an instrument has increased significantly since its initial recognition and its measurement of ECL. Based on reports from economic experts and consideration of a variety of external actual and forecast information, the Group formulates a ‘base case’ view of the future direction of relevant economic variables as well as a representative range of other possible forecast scenarios. This process involves developing two or more additional economic scenarios and considering the relative probabilities of each outcome. External information includes economic data and forecasts published by governmental bodies and monetary authorities in the Kingdom and selected private-sector and academic forecasters. The base case represents a most-likely outcome and is aligned with information used by the Group for other purposes such as strategic planning and budgeting. The other scenarios represent more optimistic and more pessimistic outcomes. Periodically, the Group carries out stress testing of more extreme shocks to calibrate its determination of these other representative scenarios.
Presentation of allowance for ECL in the statement of financial position
Loss allowances for ECL are presented in the statement of financial position as follows:
- financial assets measured at amortized cost: as a deduction from the gross carrying amount of the assets.
- debt instruments measured at FVOCI: no loss allowance is recognized in the statement of financial position because the carrying amount of these assets is their fair value. However, the loss allowance is disclosed and is recognized in the fair value reserve.
Financial liabilities
Classification and derecognition of financial liabilities
The Group classifies its financial liabilities, other than financial guarantees if any, as measured at Amortized cost. Amortized cost is calculated by considering any discount or premium and costs that are an integral part of the Effective Interest Rate (“EIR”). A liability is classified at FVTPL if it is classified as held-for trading, it is a derivative or it is designated as such on initial recognition. Financial liabilities at FVTPL are measured at fair value and net gains and losses, including any interest expense, are recognized in consolidated statement of income. The Group derecognizes a financial liability when its contractual obligations are discharged or cancelled, or expire.
(iii) Cash and cash equivalents
Cash and cash equivalents consist of cash in hand, bank balances and term deposits that have original maturity periods not exceeding three months from the date of acquisition.
(iv) Fixtures, furniture and equipment
Fixtures, furniture and equipment are initially recorded in the consolidated statement of financial position at cost. Subsequent measurement is carried out at cost less accumulated depreciation and any impairment in value. Depreciation is calculated on a straight-line basis over the estimated useful lives of the assets. The estimated useful lives of the assets for the calculation of depreciation are as follows:
Years | |
Office furniture and fixtures | 5 to 20 |
Computer equipment | 2.5 to 7 |
Motor vehicles | 4 |
Leasehold improvements (civil, construction work and fixtures) | 15 years or lease term |
Residual values, useful lives and the methods of depreciation are reviewed and adjusted as appropriate at each financial year end. Impairment reviews take place when events or changes in circumstances indicate that the carrying value may not be recoverable. The depreciation charge for the year is recognised in the consolidated statement of income on an actual basis. Similarly, impairment losses, if any, are recognised in the statement of income.
Expenditure for repairs and maintenance is charged to the consolidated statement of income. Subsequent expenditure is capitalised only if it is probable that the future economic benefits associated with the expenditure will flow to the Group. Gain/loss on sale of fixtures, furniture and equipment and Right-of-use assets is included in consolidated statement of income.
(v) Intangible assets
Separately acquired intangible assets (software) are shown at historical cost. They have a finite useful life and are subsequently carried at cost less accumulated amortisation and impairment losses. The Group amortises intangible assets with a limited useful life using straight-line method over the following periods:
Years | |
IT development and software | 3 to 7 |
(vi) Goodwill
Goodwill is initially measured at excess of the fair value of the consideration paid over the fair value of the identifiable assets and liabilities acquired. Following initial recognition, goodwill is measured at cost less any accumulated impairment losses. Goodwill is reviewed for impairment, annually or more frequently if events or changes in circumstances indicate that the carrying value may be impaired. Impairment for goodwill is determined by assessing the recoverable amount of the cash generating unit (or a group of cash generating units) to which the goodwill is related. When the recoverable amount of the cash-generating unit (or a group of cash generating units) is less than the carrying amount of the cash generating unit (or a group of cash generating units) to which goodwill has been allocated, an impairment loss is recognised in the consolidated statement of income. Impairment losses relating to goodwill cannot be reversed in future periods. Refer note 5.
(vii) Accrued and other liabilities
Liabilities are recognised for amounts to be paid in the future for goods or services received, whether billed by the supplier or not.
(viii) Provisions
Provisions are recognised when the Group has a present obligation (legal or constructive) as a result of a past event, it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation and a reliable estimate can be made of the obligation amount.
(ix) Provision for end-of-service benefits
Accruals are made at the present value of expected future payments in respect of services provided by the employees up to the end of the reporting period using the projected unit credit method. Consideration is given to the expected future wages and salary levels, experience of employee departures and periods of service. Expected future payments are discounted using market yields at the end of the reporting period of high-quality corporate bonds with terms and currencies that match, as closely as possible, the estimated future cash outflows. The benefit payments obligation is discharged as it falls due. Re-measurement (actuarial gains/losses) as a result of experience adjustments and changes in actuarial assumptions are recognised in the consolidated statement of other comprehensive income.
(x) Share based payments and shares held under employees share scheme
The cost of equity-settled transactions with employees is measured by reference to the fair value at the date on which they are granted. Grant date is the date at which the entity and an employee agree to a share based payment arrangement, being when the entity and the counterparty have a shared understanding of the terms and conditions of the arrangement. The cost of equity-settled transactions is recognised, together with a corresponding increase in equity as a reserve for a share based payment, over the period in which the performance and/or service conditions are fulfilled, ending on the date on which the relevant employees become fully entitled to the award (‘the vesting date’). The cumulative expense recognised for equity-settled transactions at each reporting date until the vesting date reflects the extent to which the vesting period has expired and the Group’s best estimate of the number of equity instruments that will ultimately vest. The charge or credit in the consolidated statement of income for a period represents the movement in cumulative expense recognised as at the beginning and end of that period.
In cases where an award is forfeited (i.e. when the vesting conditions relating to an award are not satisfied), the Group reverses the expense relating to such awards previously recognised in the statement of income. Where an equity-settled award is cancelled (other than forfeiture), it is treated as if it vested on the date of cancellation, and any expense not yet recognised for the award is recognised immediately. The value of the shares repurchased, including costs associated with the acquisition, is recognized as a deduction from equity. The Company retains shares under employees share scheme, which represents treasury shares.
(xi) Impairment of non-financial assets
The Group assesses at each reporting date whether there is an indication that an asset may be impaired. If any indication exists, or when annual impairment testing for an asset is required, the Group estimates the asset’s recoverable amount. An asset’s recoverable amount is the higher of an asset’s or cash-generating unit’s (CGU) fair value less costs to sell and its value in use and is determined for an individual asset, unless the asset does not generate cash inflows that are largely independent of those from other assets or groups of assets. When the carrying amount of an asset or CGU exceeds its recoverable amount, the asset is considered impaired and is written down to its recoverable amount. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset. In determining fair value less costs to sell, recent market transactions are taken into account, if available. If no such transactions can be identified, an appropriate valuation model is used. These calculations are corroborated by valuation multiples, quoted share prices or other available fair value indicators.
The Group bases its impairment calculation on detailed budgets and forecast calculations, which are prepared separately for each of the Group’s CGUs to which the individual assets are allocated. These budgets and forecast calculations generally cover a period of three to five years. For longer periods, a long-term growth rate is calculated and applied to project future cash flows after the fifth year. Impairment losses of continuing operations are recognised in the consolidated statement of income.
For assets, excluding goodwill, an assessment is made at each reporting date whether there is any indication that previously recognised impairment losses may no longer exist or may have decreased. If such indication exists, the Group estimates the asset’s recoverable amount. A previously recognised impairment loss is reversed only if there has been a change in the assumptions used to determine the asset’s recoverable amount since the last impairment loss was recognised. The reversal is limited so that the carrying amount of the asset does not exceed its recoverable amount nor exceed the carrying amount that would have been determined, net of depreciation, had no impairment loss been recognised for the asset in prior years. Such a reversal is recognised in the statement of income.
(xii) De-recognition
Financial asset
A financial asset (or, where applicable, a part of a financial asset or part of a group of similar financial assets) is derecognised when:
- the rights to receive cash flows from the asset have expired; or
- the Group has transferred its rights to receive cash flows from the asset or has assumed an obligation to pay the received cash flows in full without material delay to a third party under a ‘pass-through’ arrangement; and either (a) the Group has transferred substantially all the risks and rewards of the asset, or (b) the Group has neither transferred nor retained substantially all the risks and rewards of the asset, but has transferred control of the asset.
When the Group has transferred its rights to receive cash flows from an asset or has entered into a ‘pass-through’ arrangement, it evaluates if and to what extent it has retained the risks and rewards of ownership. When it has neither transferred nor retained substantially all of the risks and rewards of the asset, nor transferred control of the asset, the asset is recognised to the extent of the Group’s continuing involvement in the asset. In that case, the Group also recognises an associated liability. The transferred asset and the associated liability are measured on a basis that reflects the rights and obligations that the Group has retained. Continuing involvement that takes the form of a guarantee over the transferred asset is measured at the lower of the original carrying amount of the asset and the maximum amount of consideration that the Group could be required to repay.
Financial liability
A financial liability is derecognized when the obligation under the liability is discharged, cancelled or expired.
(xiii) Revenue recognition
Investment and commission income
Investment income or loss comprises of unrealised and realised gains and losses on investments. Commission income on term deposits is recognised using the effective interest method in the consolidated statement of income.
Other revenues
Other revenue represents revenue generated from operations of Bupa Arabia For Third Party Administration through claims management and handling services. The Group recognizes revenue from contracts, with customers based on a five-step model as set out in IFRS 15. Accordingly, the Company recognizes revenue when or as a performance obligation is satisfied. i.e. when control of the services pertaining to the respective performance obligation is transferred to the customer. Revenue primarily represents services revenue. Revenue from providing services is recognised in the accounting period in which the services are rendered. Revenue is recognised based on the actual service provided to the end of the reporting period because the customer receives and uses the benefits simultaneously. This is determined by multiplying the number of members served with a fixed and pre-agreed rate with the customer in accordance with the terms of the contract. Customers are invoiced on a monthly basis and consideration is payable when invoiced. There were no contract assets or contract liabilities at the end of the reporting period as all services provided were already invoiced and there were no advance payments from customers as at that date.
(xiv) Leases
Right-of-use assets
The Group recognises right-of-use assets at the commencement date of the lease (i.e., the date the underlying asset is available for use). The Group applies the cost model, and measure right of use asset at cost;
- less any accumulated amortization and any accumulated impairment losses; and
- adjusted for any re-measurement of the lease liability for lease modifications.
Unless the Group is reasonably certain to obtain ownership of the leased asset at the end of the lease term, generally, the initial carrying value of a right-of-use asset would be equal to the lease liability. However, if there are additional costs such as site preparation, non-refundable deposits, application money, other expenses related to transaction etc. it needs to be added to the right of use asset value.
The recognised right-of-use assets are amortized on a straight-line basis over the shorter of its estimated useful life and the lease term. right-of-use assets are subject to impairment. The estimated useful lives of the assets for the calculation of amortization are as follows:
Years | |
Right-of-use assets | 5 to 20 |
Lease liabilities
On initial recognition, the lease liability is the present value of all remaining payments to the lessor, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the Group’s incremental borrowing rate. Generally, the Group uses its incremental borrowing rate as the discount rate.
After the commencement date, Group measures the lease liability by:
- Increasing the carrying amount to reflect interest on the lease liability.
- Reducing the carrying amount to reflect the lease payments made and;
- Re-measuring the carrying amount to reflect any re-assessment or lease modification.
The lease liability is measured at amortized cost using the effective interest method. It is re-measured when there is a change in future lease payments arising from a change in an index or rate, if there is a change in the Group’s estimate of the amount expected to be payable under a residual value guarantee, or if the Group changes its assessment of whether it will exercise a purchase, extension or termination option.
When the lease liability is re-measured in this way, a corresponding adjustment is made to the carrying amount of the right-of-use asset, or is recorded in profit or loss if the carrying amount of the right-of-use asset has been reduced to zero.
Short-term leases and leases of low-value assets
The Group has elected not to recognize right-of-use assets and lease liabilities for short-term leases that have a lease term of 12 months or less and leases of low-value assets, including IT equipment. The Group recognizes the lease payments associated with these leases as an expense on a straight-line basis over the lease term.
(xv) Zakat and income tax
Zakat
The Group is subject to zakat in accordance with the regulations of the Zakat, Tax, and Customs Authority (ZATCA). Zakat is calculated based on higher of approximate zakat base and adjusted profit and charged to profit or loss. Additional zakat, if any, is accounted for when determined to be required for payment.
Amounts accrued for zakat expense in one year may have to be adjusted in a subsequent year if the estimate of the annual charge changes.
Income tax
The income tax expense or credit for the year is the tax payable on the current year’s taxable income, based on the applicable income tax rate, adjusted by changes in deferred tax assets and liabilities attributable to temporary differences and to unused tax losses. The current income tax charge is calculated on the basis of the tax laws enacted or substantively enacted at the end of the reporting period and generate taxable income. Management periodically evaluates positions taken in tax returns with respect to situations in which applicable tax regulation is subject to interpretation. It establishes provisions, where appropriate, on the basis of amounts expected to be paid to the tax authorities.
Deferred Tax
Deferred income tax is provided using the liability method on temporary differences arising between the carrying amounts of assets and liabilities for financial reporting purposes and amounts used for taxation purposes. The amount of deferred tax provided is based on the expected manner of realisation or settlement of the carrying amounts of assets and liabilities using the tax rates enacted or substantively enacted at the reporting date. A deferred tax asset is recognised only to the extent that it is probable that future taxable profits will be available and the credits can be utilised. Deferred tax asset is reduced to the extent that it is no longer probable that the related tax benefits will be realised.
Deferred tax assets and liabilities are not recognised for temporary differences between the carrying amount and tax bases of investments in foreign operations where the Group is able to control the timing of the reversal of the temporary differences and it is probable that the differences will not reverse in the foreseeable future.
Deferred tax assets and liabilities are offset where there is a legally enforceable right to offset current tax assets and liabilities and where the deferred tax balances relate to the same taxation authority. Current tax assets and tax liabilities are offset where the entity has a legally enforceable right to offset and intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously. Current and deferred tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.
(xvi) Foreign currencies
The accounting records of the Group are maintained in Saudi Riyals. Transactions in foreign currencies are recorded in Saudi Riyals at the approximate rate of exchange ruling at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated at the spot rate at the reporting date. All differences are taken to the statement of income.
(xvii) Offsetting
Financial assets and financial liabilities are offset and the net amount is reported in the consolidated statement of financial position only when there is a legally enforceable right to offset the recognised amounts and there is an intention to settle on a net basis, or to realise the assets and settle the liabilities simultaneously. Income and expenses are not offset in the statement of income unless required or permitted by any accounting standard or interpretation, as specifically disclosed in the accounting policies of the Group.
(xviii) Cash dividends to shareholders
The Group recognises a liability for cash distributions to shareholders of the Group when the distribution is authorised and is no longer at the discretion of the Group. A distribution is authorised when it is approved by the shareholders and Insurance Authority. A corresponding amount is recognised in equity.
(xix) Statutory reserve
The Group allocates 20% of its net income from shareholders operations each year to the statutory reserve until it has built up a reserve equal to the share capital, as mandated by relevant regulations. The reserve is not available for distribution.
4. Explanation to transition to IFRS 17, IFRS 9 and other changes
As stated in note 2, these consolidated financial statements are prepared in accordance with the requirements of IFRS as endorsed in the Kingdom of Saudi Arabia. The Group has adopted IFRS 17 and IFRS 9 from its effective date i.e 1 January 2023.
The accounting policies set out in note 3 have been applied in preparing the consolidated financial statements for the year ended 31 December 2023 and in the preparation of an opening IFRS 17 and IFRS 9 statement of financial position at 1 January 2022 (the Group’s date of transition) and 31 December 2022.
In preparing its opening IFRS 17 and IFRS 9 statement of financial position, the Group has adjusted amounts reported previously in financial statements under IFRS 4 and IAS 39.
Reclassification impact on the consolidated statement of financial position on adoption of IFRS 17
Presentation changes in the consolidated statement of financial position are introduced by IFRS 17. The previously reported line items: premiums receivable - net, deferred policy acquisition costs, insurance operations’ surplus payable, unearned premiums, outstanding claims, claims incurred but not reported, premium deficiency reserve, claims handling reserve are presented together by portfolio on a single line called insurance contract liabilities. The previously reported line items: reinsurers’ share of unearned premiums, reinsurers’ share of outstanding claims, reinsurers’ share of claims incurred but not reported, reinsurers’ balances payable are presented together by portfolio on a single line called reinsurance contract assets or liabilities.
Presentation is driven by portfolios which are composed of groups of contracts covering similar risks and which are managed together. Portfolios of insurance and reinsurance contracts are presented separately between:
- Portfolios of insurance contracts that are assets;
- Portfolios of reinsurance contracts that are assets;
- Portfolios of insurance contracts that are liabilities; and
- Portfolios of reinsurance contracts that are liabilities.
Remeasurement impact on the consolidated statement of financial position on adoption of IFRS 17
Drivers of Changes | Impact on equity on transition
to IFRS 17 on 1 January 2022 SR ’000 |
Changes in measurement of insurance contract liabilities | (35,017) |
Changes in measurement of reinsurance contract assets | 682 |
Total impact | (34,335) |
Drivers of Changes | Impact on liabilities on transition
to IFRS 17 on 1 January 2022 SR ’000 |
Risk adjustment | (29,187) |
Loss component on onerous contracts | (5,830) |
Total impact | (35,017) |
Drivers of Changes | Impact on liabilities on transition
to IFRS 17 on 1 January 2022 SR ’000 |
Risk adjustment | 682 |
Reclassification impact on the consolidated statement of financial position on adoption of IFRS 9
The following table and the accompanying notes below explain the original measurement categories under IAS 39 and the new measurement categories under IFRS 9 for each class of the Group’s financial assets and financial liabilities, inclusive of the expected credit losses, as at 1 January 2022:
Particulars | Original
classification under IAS 39 |
New
classification under IFRS 9 |
Original
carrying amount under IAS 39 SR ’000 |
New carrying
amount under IFRS 9 SR ’000 |
Financial assets: | ||||
Cash and cash equivalents | Am ortized cost | Am ortized cost | 960,758 | 960,585 |
Investments: | ||||
Insurance operations – | ||||
Mutual funds | Availa ble for sale | FVTPL | 36,759 | 36,759 |
Mutual funds | Held for trading | FVTPL | 1,790,185 | 1,790,185 |
Sukuks | Availa ble for sale | FVOCI | 654,471 | 654,471 |
Sukuks | Held for trading | FVTPL | 18,014 | 18,014 |
Sukuks | Held to maturity | Am ortized cost | 100,000 | 99,982 |
Accrued interest on Sukuks | Held to maturity | Am ortized cost | 736 | 736 |
Shareholder operations – | ||||
Equity | Availa ble for sale | FVOCI | 58,070 | 58,070 |
Equity | Availa ble for sale | FVTPL | 271,129 | 271,129 |
Mutual funds | Availa ble for sale | FVTPL | 144,933 | 144,933 |
Mutual funds | Held for trading | FVTPL | 1,394,691 | 1,394,691 |
Investments in discretionary portfolios | Availa ble for sale | FVOCI | 50,189 | 50,189 |
Sukuks | Availa ble for sale | FVOCI | 899,038 | 899,038 |
Sukuks | Held for trading | FVTPL | 55,044 | 55,044 |
Sukuks | Held to maturity | Am ortized cost | 231,250 | 231,208 |
Accrued interest on Sukuks | Held to maturity | Am ortized cost | 1,640 | 1,640 |
Term deposits: | ||||
Insurance operations | Held to maturity | Am ortized cost | 2,007,922 | 2,007,560 |
Shareholder operations | Held to maturity | Am ortized cost | 1,085,798 | 1,085,603 |
Statutory deposits | Held to maturity | Am ortized cost | 134,885 | 134,863 |
Other financial assets | Held to maturity | Am ortized cost | 17,511 | 17,511 |
The changes in the classification of financial assets are predominantly due to the mandatory classification of equity instruments (including mutual funds) at FVTPL except for those which on transition the Group has elected to present the changes in fair value in OCI. Sukuks held for trading are required to be classified as FVTPL. Sukuks which meet the requirements of the IFRS 9 business models hold to collect and sell are classified as FVOCI. The remaining financial assets which have been classified as amortised cost meet the criteria of held to collect business model. There are no changes in the classification of financial liabilities in the transition from IAS 39 to IFRS 9.
Remeasurement impact on the consolidated statement of financial position on adoption of IFRS 9
The following table reconciles the impairment allowance and provision recorded as per the requirements of IAS 39 as at 31 December 2021 to opening ECL allowance determined in accordance with IFRS 9 as at 1 January 2022. At the transition date and at the reporting date all financial assets were in Stage 1.
Particulars | 31 Dec 2021
(IAS 39) SR ’000 |
Re-
classification SR ’000 |
Re-
measurement SR ’000 |
1 Jan 2022
(IFRS 9) SR ’000 |
Financial assets at amortized cost (IFRS 9) | ||||
Impairment on amortized cost assets (Sukuks) | – | – | 60 | 60 |
Impairment on term deposits | – | – | 557 | 557 |
Impairment on cash and cash equivalents | – | – | 173 | 173 |
Impairment on statutory deposits | – | – | 22 | 22 |
Financial assets at FVOCI (IFRS 9) | ||||
Impairment on assets classified as FVOCI charged to profit or loss | – | – | 277 | 277 |
Total | – | – | 1,089 | 1,089 |
Reconciliation of consolidated statement of financial position as at 1 January 2022.
1 January 2022 (Unaudited) | ||||||
Pre-adoption
of IFRS 17 & IFRS 9 SR ’000 |
IFRS 17 | IFRS 9 | Post adoption
of IFRS 17 & IFRS 9 SR ’000 |
|||
Reclassification
SR ’000 |
Remeasurement
SR ’000 |
Reclassification
SR ’000 |
Remeasurement
SR ’000 |
|||
Assets | ||||||
Cash and cash equivalents | 960,758 | – | – | – | (173) | 960,585 |
Premiums receivable – net | 1,761,300 | (1,761,300) | – | – | – | – |
Reinsurers’ share of unearned premiums | 27,935 | (27,935) | – | – | – | – |
Reinsurers’ share of outstanding claims | 7,207 | (7,207) | – | – | – | – |
Reinsurers’ share of claims incurred but not reported | 7,829 | (7,829) | – | – | – | – |
Reinsurance contract assets | – | 58,430 | 682 | – | – | 59,112 |
Deferred policy acquisition costs | 201,042 | (201,042) | – | – | – | – |
Term deposits | 3,093,720 | – | – | – | (557) | 3,093,163 |
Investments | 5,703,773 | – | – | (5,703,773) | – | – |
Financial assets at amortised cost – net | – | – | – | 333,626 | (60) | 333,566 |
Financial assets at fair value | – | – | – | 5,372,523 | – | 5,372,523 |
Prepaid expenses and other assets | 113,254 | 173,215 | – | (2,376) | – | 284,093 |
Fixtures, furniture and equipment – net | 69,771 | – | – | – | – | 69,771 |
Deferred tax asset | 39,735 | – | – | – | 94 | 39,829 |
Right-of-use assets – net | 112,616 | – | – | – | – | 112,616 |
Intangible assets – net | 67,277 | – | – | – | – | 67,277 |
Statutory deposit | 120,000 | – | – | – | (22) | 119,978 |
Accrued income on statutory deposit | 14,885 | – | – | – | – | 14,885 |
Goodwill | 98,000 | – | – | – | – | 98,000 |
Total assets | 12,399,102 | (1,773,668) | 682 | – | (718) | 10,625,398 |
Liabilities | ||||||
Accrued and other liabilities | 604,774 | (302,254) | – | – | – | 302,520 |
Insurance contract liabilities | – | 5,559,328 | 35,017 | – | – | 5,594,345 |
Reinsurance contract liabilities | – | 25,397 | – | – | – | 25,397 |
Lease liability | 125,333 | – | – | – | – | 125,333 |
Insurance operations’ surplus payable | 190,060 | (190,060) | – | – | – | – |
Reinsurers’ balances payable | 25,397 | (25,397) | – | – | – | – |
Unearned premiums | 4,709,555 | (4,709,555) | – | – | – | – |
Outstanding claims | 601,168 | (601,168) | – | – | – | – |
Claims incurred but not reported | 1,413,888 | (1,413,888) | – | – | – | – |
Premium deficiency reserve | 74,602 | (74,602) | – | – | – | – |
Claims handling reserve | 21,797 | (21,797) | – | – | – | – |
Due to related parties | 33,723 | (19,672) | – | – | – | 14,051 |
Provision for end-of-service benefits | 152,286 | – | – | – | – | 152,286 |
Provision for zakat and income tax | 236,610 | – | – | – | – | 236,610 |
Accrued income payable to Insurance Authority | 14,885 | – | – | – | – | 14,885 |
Total liabilities | 8,204,078 | (1,773,668) | 35,017 | – | – | 6,465,427 |
Equity | ||||||
Share capital | 1,200,000 | – | – | – | – | 1,200,000 |
Statutory reserve | 992,210 | – | – | – | – | 992,210 |
Share based payments reserve | 43,500 | – | – | – | – | 43,500 |
Shares held under employees share scheme | (53,356) | – | – | – | – | (53,356) |
Retained earnings | 1,790,700 | – | (34,335) | 25,187 | (995) | 1,780,557 |
Re-measurement reserve for end-of-service benefits | (23,638) | – | – | – | – | (23,638) |
Investments fair value reserve | 245,608 | – | – | (25,187) | 277 | 220,698 |
Total equity | 4,195,024 | – | (34,335) | – | (718) | 4,159,971 |
Total liabilities and equity | 12,399,102 | (1,773,668) | 682 | – | (718) | 10,625,398 |
Reconciliation of consolidated statement of financial position as at 31 December 2022
31 December 2022 (Unaudited) | ||||||
Pre-adoption
of IFRS 17 & IFRS 9 SR ’000 |
IFRS 17 | IFRS 9 | Post adoption
of IFRS 17 & IFRS 9 SR ’000 |
|||
Reclassification
SR ’000 |
Remeasurement
SR ’000 |
Reclassification
SR ’000 |
Remeasurement
SR ’000 |
|||
Assets | ||||||
Cash and cash equivalents | 1,288,297 | – | – | – | (336) | 1,287,961 |
Premiums receivable – net | 2,159,183 | (2,159,183) | – | – | – | – |
Reinsurers’ share of unearned premiums | 48,265 | (48,265) | – | – | – | – |
Reinsurers’ share of outstanding claims | 7,221 | (7,221) | – | – | – | – |
Reinsurers’ share of claims incurred but not reported | 12,602 | (12,602) | – | – | – | – |
Reinsurance contract assets | – | 27,256 | 899 | – | – | 28,155 |
Deferred policy acquisition costs | 264,931 | (264,931) | – | – | – | – |
Term deposits | 6,408,489 | – | – | – | (1,641) | 6,406,848 |
Investments | 3,374,302 | – | – | (3,374,302) | – | – |
Financial assets at amortised cost – net | – | – | – | 526,326 | (138) | 526,188 |
Financial assets at fair value | – | – | – | 2,852,234 | – | 2,852,234 |
Prepaid expenses and other assets | 147,763 | 262,725 | 4,289 | (4,258) | – | 410,519 |
Fixtures, furniture and equipment – net | 63,643 | – | – | – | – | 63,643 |
Deferred tax asset | 40,151 | – | 120 | – | 240 | 40,511 |
Due from related parties | – | 3,316 | – | – | – | 3,316 |
Right-of-use assets – net | 165,947 | – | – | – | – | 165,947 |
Intangible assets – net | 65,413 | – | – | – | – | 65,413 |
Statutory deposit | 150,000 | – | – | – | (39) | 149,961 |
Accrued income on statutory deposit | 16,235 | – | – | – | – | 16,235 |
Goodwill | 98,000 | – | – | – | – | 98,000 |
Total assets | 14,310,442 | (2,198,905) | 5,308 | – | (1,914) | 12,114,931 |
Liabilities | ||||||
Accrued and other liabilities | 871,560 | (340,845) | – | – | – | 530,715 |
Insurance contract liabilities | – | 6,602,801 | 96,384 | – | – | 6,699,185 |
Reinsurance contract liabilities | – | 2,605 | – | – | – | 2,605 |
Lease liability | 184,682 | – | – | – | – | 184,682 |
Insurance operations’ surplus payable | 208,021 | (208,021) | – | – | – | – |
Reinsurers’ balances payable | 2,605 | (2,605) | – | – | – | – |
Unearned premiums | 5,695,725 | (5,695,725) | – | – | – | – |
Outstanding claims | 601,366 | (601,366) | – | – | – | – |
Claims incurred but not reported | 1,867,017 | (1,867,017) | – | – | – | – |
Premium deficiency reserve | 22,982 | (22,982) | – | – | – | – |
Claims handling reserve | 23,470 | (23,470) | – | – | – | – |
Due to related parties | 42,280 | (42,280) | – | – | – | – |
Provision for end-of-service benefits | 154,054 | – | – | – | – | 154,054 |
Provision for zakat and income tax | 326,566 | – | – | – | – | 326,566 |
Accrued income payable to Insurance Authority | 16,235 | – | – | – | – | 16,235 |
Total liabilities | 10,016,563 | (2,198,905) | 96,384 | – | – | 7,914,042 |
Equity | ||||||
Share capital | 1,500,000 | – | – | – | – | 1,500,000 |
Statutory reserve | 1,164,724 | – | – | – | – | 1,164,724 |
Share based payments reserve | 54,268 | – | – | – | – | 54,268 |
Shares held under employees share scheme | (78,235) | – | – | – | – | (78,235) |
Retained earnings | 1,709,186 | – | (91,076) | 26,015 | (2,534) | 1,641,591 |
Re-measurement reserve for end-of-service benefits | (7,043) | – | – | – | – | (7,043) |
Investments fair value reserve | (49,021) | – | – | (26,015) | 620 | (74,416) |
Total equity | 4,293,879 | – | (91,076) | – | (1,914) | 4,200,889 |
Total liabilities and equity | 14,310,442 | (2,198,905) | 5,308 | – | (1,914) | 12,114,931 |
Reclassification impact on consolidated statement of income on adoption of IFRS 17
The line-item descriptions in the consolidated statement of income have been changed significantly compared with prior year. Previously, the Group reported the following line items:
- Gross premiums written
- Reinsurance premiums ceded – Local
- Reinsurance premiums ceded – International
- Changes in unearned premiums – net
- Gross claims paid
- Reinsurers’ share of claims paid
- Changes in outstanding claims
- Changes in claims incurred but not reported
- Changes in premium deficiency reserve
- Changes in claims handling reserves
- Reinsurance share of changes in outstanding claims
- Reinsurance share of changes in claims incurred but not reported
- Policy acquisition costs
- Allowance for doubtful receivables
- General and administrative expenses
- Selling and marketing expenses
- Other income – net
- Income attributed to the insurance operations
Instead, IFRS 17 requires separate presentation of:
- Insurance revenue
- Insurance service expense
- Net expenses from reinsurance contracts held
- Other operating expenses
Remeasurement impact on consolidated statement of comprehensive income on adoption of IFRS 17 for the year ended 31 December 2022
The remeasurement impact in the consolidated statement of income on adoption of IFRS 17 is on account of the following:
Drivers of Changes | Year ended 31 December 2022 SR ’000 |
Risk adjustment | (22,729) |
Loss component on onerous contract | (32,750) |
Expected premium adjustment | (5,672) |
Reclassification impact on consolidated statement of comprehensive income on adoption of IFRS 9 for the year ended 31 December 2022
- Net impairment loss under IFRS 9 is disclosed separately on the statement of income. Under IAS 39, impairment loss was disclosed as part of investment income.
- Investment income on financial assets at amortised costs and on financial assets at fair value are shown separately on the statement of income instead of presented previously as one line item.
- Under IAS 39, changes in the fair value of both investment in debt instruments and investment in equity instruments classified as available-for-sale were shown together on the statement of comprehensive income for the year ended 31 December 2022. On transition to IFRS 9, the net fair value loss of SR 294.6 million was reclassified from “changes in available-for-sale investments” and shown separately as fair value loss of SR 192.1 million on equity instruments and a fair value loss of SR 102.5 million on debt instruments. Those instruments have been reclassified from available for sale to financial assets at FVOCI on transition.
Reconciliation of consolidated statement of income for the year ended 31 December 2022
31 December 2022 | ||||||
Pre-adoption
of IFRS 17 & IFRS 9 SR ’000 |
IFRS 17 | IFRS 9 | Post adoption
of IFRS 17 & IFRS 9 SR ’000 |
|||
Reclassification
SR ’000 |
Remeasurement
SR ’000 |
Reclassification
SR ’000 |
Remeasurement
SR ’000 |
|||
Revenues | ||||||
Gross premiums written | 13,896,883 | (13,896,883) | – | – | – | – |
Reinsurance premiums ceded – Local | (175) | 175 | – | – | – | – |
Reinsurance premiums ceded – International | (94,107) | 94,107 | – | – | – | – |
Net premiums written | 13,802,601 | (13,802,601) | – | – | – | – |
Changes in unearned premiums – net | (965,840) | 965,840 | – | – | – | – |
Net premiums earned | 12,836,761 | (12,836,761) | – | – | – | – |
Other revenues | 42,633 | – | – | – | – | 42,633 |
Total revenues | 12,879,394 | (12,836,761) | – | – | – | 42,633 |
Insurance revenue | – | 12,878,783 | (5,672) | – | – | 12,873,111 |
Insurance service expense | – | (12,150,337) | (55,696) | – | – | (12,206,033) |
Net expenses from reinsurance contracts held | – | (29,667) | 217 | – | – | (29,450) |
Net insurance service result | – | 698,779 | (61,151) | – | – | 637,628 |
Underwriting costs & expenses | ||||||
Gross claims paid | (10,565,431) | 10,565,431 | – | – | – | – |
Reinsurers’ share of claims paid | 39,497 | (39,497) | – | – | – | – |
Net claims paid | (10,525,934) | 10,525,934 | – | – | – | – |
Changes in outstanding claims | (198) | 198 | – | – | – | – |
Changes in claims incurred but not reported | (453,129) | 453,129 | – | – | – | – |
Changes in premium deficiency reserve | 51,620 | (51,620) | – | – | – | – |
Changes in claims handling reserves | (1,673) | 1,673 | – | – | – | – |
Reinsurance share of changes in outstanding claims | 14 | (14) | – | – | – | – |
Reinsurance share of changes in claims incurred but not reported | 4,773 | (4,773) | – | – | – | – |
Net claims incurred | (10,924,527) | 10,924,527 | – | – | – | – |
Policy acquisition costs | (578,156) | 578,156 | – | – | – | – |
Other costs | (16,378) | – | – | – | – | (16,378) |
Total underwriting costs and expenses | (11,519,061) | 11,502,683 | – | – | – | (16,378) |
Investment income on financial assets at amortised cost – net | – | – | – | 167,197 | – | 167,197 |
Investment income on financial assets at fair value | – | – | – | 385,793 | 829 | 386,622 |
Net impairment loss on financial assets | – | – | – | – | (1,685) | (1,685) |
Net underwriting income | 1,360,333 | (635,299) | (61,151) | 552,990 | (856) | 1,216,017 |
Other operating income/(expenses) | ||||||
Allowance for doubtful receivables | (40,885) | 40,885 | – | – | – | – |
General and administrative expenses | (667,145) | 667,145 | – | – | – | – |
Selling and marketing expenses | (135,975) | 135,975 | – | – | – | – |
Investment income – net | 552,990 | – | – | (552,990) | – | – |
Other income – net | 22,866 | (22,866) | – | – | – | – |
Total other operating income/(expenses) | (268,149) | 821,139 | – | (552,990) | – | – |
Income before surplus, zakat & income tax | 1,092,184 | 185,840 | (61,151) | – | (856) | 1,216,017 |
Income attributed to the insurance operations (transfer to surplus payable) | (65,303) | 65,303 | – | – | – | – |
Other operating expenses | – | (251,143) | – | – | 4,289 | (246,854) |
Income attributed to the shareholders before zakat and income tax | 1,026,881 | – | (61,151) | – | 3,433 | 969,163 |
Zakat charge | (72,938) | – | – | – | – | (72,938) |
Income tax charge | (91,374) | – | – | – | 266 | (91,108) |
Net income attributed to the shareholders after zakat and income tax | 862,569 | – | (61,151) | – | 3,699 | 805,117 |
Reconciliation of consolidated statement of comprehensive income for the year ended 31 December 2022
31 December 2022 | ||||||
Pre-adoption
of IFRS 17 & IFRS 9 SR ’000 |
IFRS 17 | IFRS 9 | Post adoption
of IFRS 17 & IFRS 9 SR ’000 |
|||
Reclassification
SR ’000 |
Remeasurement
SR ’000 |
Reclassification
SR ’000 |
Remeasurement
SR ’000 |
|||
NET INCOME ATTRIBUTED TO THE SHAREHOLDERS AFTER ZAKAT AND INCOME TAX | 862,569 | – | (61,151) | – | 3,699 | 805,117 |
Other comprehensive income/(loss) | ||||||
A. Items that will not be reclassified to consolidated statement of income in subsequent years |
||||||
Actuarial gains on end-of-service benefits | 16,595 | – | – | – | – | 16,595 |
Net changes in fair value of investments measured at FVOCI – equity instruments | – | – | – | (192,175) | 1,450 | (190,725) |
B. Items that are or may be reclassified to consolidated statements of income in subsequent years |
||||||
Net changes in fair value of available-for-sale investments | (294,629) | – | – | 294,629 | – | – |
Net changes in fair value of investments measured at FVOCI – debt instrument | – | – | – | (102,454) | (2,279) | (104,733) |
Net changes in allowance for expected credit losses of FVOCI – debt instruments | – | – | – | – | 344 | 344 |
Total other comprehensive loss | (278,034) | – | – | – | (485) | (278,519) |
Total comprehensive income for the year | 584,535 | – | (61,151) | – | 3,214 | 526,598 |
Details of (decrease)/increase in the retained earnings resulting from transition to IFRS 17 and IFRS 9 are as follows:
Drivers of Changes | Share capital
SR ’000 |
Statutory
reserve SR ’000 |
Share based
payments reserve SR ’000 |
Shares
held under employees share scheme SR ’000 |
Retained
earnings SR ’000 |
Re-measurement
reserve for end-of service benefits SR ’000 |
Investments
fair value reserve SR ’000 |
Total equity
SR ’000 |
1 January 2022 (previously reported) | 1,200,000 | 992,210 | 43,500 | (53,356) | 1,790,700 | (23,638) | 245,608 | 4,195,024 |
Reclassifications under IFRS 9 | – | – | – | – | 25,187 | – | (25,187) | – |
Recognition of expected credit losses under IFRS 9 | – | – | – | – | (1,089) | – | 277 | (812) |
Deferred tax adjustment related to IFRS 9 | – | – | – | – | 94 | – | – | 94 |
Remeasurement under IFRS 17 | – | – | – | – | (34,335) | – | – | (34,335) |
1 January 2022 (restated) | 1,200,000 | 992,210 | 43,500 | (53,356) | 1,780,557 | (23,638) | 220,698 | 4,159,971 |
31 December 2022 (previously reported) | 1,500,000 | 1,164,724 | 54,268 | (78,235) | 1,709,186 | (7,043) | (49,021) | 4,293,879 |
Reclassifications under IFRS 9 | – | – | – | – | 26,015 | – | (26,015) | – |
Recognition of expected credit losses under IFRS 9 | – | – | – | – | (2,774) | – | 620 | (2,154) |
Deferred tax adjustment related to IFRS 9 | – | – | – | – | 240 | – | – | 240 |
Deferred tax adjustment related to IFRS 17 | – | – | – | – | 120 | – | – | 120 |
Remeasurement under IFRS 17 | – | – | – | – | (91,196) | – | – | (91,196) |
31 December 2022 (restated) | 1,500,000 | 1,164,724 | 54,268 | (78,235) | 1,641,591 | (7,043) | (74,416) | 4,200,889 |
Reclassification adjustment under IFRS 9 relates to reclassification of equity instruments as FVTPL which were classified as available for sales under IAS 39. Refer to note above for explanation of impact.
Other reclassifications
As at 31 December 2022, the order of presentation of Goodwill and deferred tax assets on the consolidated statement of financial position amounting to SR 98 million and SR 40.151 million respectively, were rearranged to reflect a better presentation in terms of order of liquidity. In prior years, fair value reserves of investments classified as available-for-sale were disaggregated and presented separately between policyholders’ operation and shareholders’ operation SR 25.054 million and SR 23.967 million on the consolidated statement of financial position and on the consolidated statement of changes in equity respectively. Similarly, the changes in the fair values of those investments were disaggregated and presented separately between policyholders’ operation and shareholders’ operation on the consolidated statement of comprehensive income. This has now been combined and presented as one line item on the statement of financial position and the statement of changes in equity. Changes in the fair values of those investments are now presented as one line item on the statement of comprehensive income and on the statement of changes in equity.
5. Goodwill
on 31 December 2008, the Group entered into an agreement with Bupa Middle East Limited E.C. (the “Seller”), a related party, pursuant to which it acquired the Seller’s insurance operations in the Kingdom of Saudi Arabia, effective from 1 January 2009. The acquisition transaction was approved by SAMA and resulted in goodwill of SR 98 million. The entire amount was paid in the previous years, to the Seller, after obtaining the required regulatory approvals.
The Group’s management annually carry out impairment test in respect of the above-mentioned goodwill. Management conducted the impairment exercise for the year ended 31 December 2023. The recoverable amount of operations has been determined based on value in use. The calculations use cash flow projections based on financial budgets approved by management covering a three-year period. Cash flows beyond the three-year period are extrapolated using the estimated growth rates stated below. These growth rates are consistent with forecasts included in industry reports specific to the industry in which the Company operates. The goodwill is allocated to the corporate segment of the Company. The three key assumptions used in the test are the discount rate, estimated future cash flows from the business and insurance service revenue and expense growth rates as follows:
- An average discount rate of 12% (2022: 12%) was used to discount future cash flows.
- Insurance service revenue average growth rate of 9.8% was used for the first three years. Thereafter, a growth rate of 3% (2022: 3%) was used in the terminal value calculation.
- Insurance service expense average growth rate of 9.9% was used for the first three years. Thereafter, a growth rate of 3% (2022: 3%) was used in the terminal value calculation.
- A change in discount rate by +/- 3% with other variables held constant would not result in impairment of goodwill.
- A change in insurance service revenue growth rate by +/- 3% basis point with other variables held constant would not result in impairment of goodwill.
- A change in insurance service expense growth rate by +/- 3% basis point with other variables held constant would not result in impairment of goodwill.
- A change in terminal growth rate by +/- 3% basis point with other variables held constant would not result in impairment of goodwill.
6. Cash and cash equivalents
Cash and cash equivalents consist of the following:
2023 (SR ’000) | |||
Insurance
operations SR ’000 |
S
hareholders’
operations SR ’000 |
Total
SR ’000 |
|
Bank balances | 897,625 | 358,651 | 1,256,276 |
Less: Impairment allowance | (300) | (80) | (380) |
897,325 | 358,571 | 1,255,896 |
2022 (SR ’000) | |||
Insurance
operations SR ’000 |
Shareholders’
operations SR ’000 |
Total
SR ’000 |
|
Bank balances | 649,270 | 639,027 | 1,288,297 |
Less: Impairment allowance | (173) | (163) | (336) |
649,097 | 638,864 | 1,287,961 |
1 January 2022 (SR ’000) | |||
Insurance
operations SR ’000 |
Shareholders’
operations SR ’000 |
Total
SR ’000 |
|
Bank balances | 430,300 | 30,067 | 460,367 |
Term deposits | 500,391 | – | 500,391 |
Less: Impairment allowance | (168) | (5) | (173) |
930,523 | 30,062 | 960,585 |
(31 December 2022: SR 61 million).
7. Insurance and reinsurance contracts
Note | 2023
SR ’000 |
2022
SR ’000 |
|
Insurance contract liabilities | |||
Corporate | 7.1 a | 7,097,020 | 5,729,150 |
SMEs and others | 7.1 b | 1,170,176 | 970,035 |
8,267,196 | 6,699,185 | ||
Reinsurance contract assets | 7.2 | 74,090 | 28,155 |
Reinsurance contract liabilities | 7.2 | – | 2,605 |
7.1. Analysis by remaining coverage and incurred claims for insurance contracts
a. Corporate
2023 (SR ’000) | |||||
Liability for remaining co verage (LRC) | Liability for incurred claims (LIC) | ||||
Excluding
loss component |
Loss
component |
Estimate of
pr esent value o f cash flows |
RA for
no n-financial risk |
Total | |
Insurance contracts issued: | |||||
Opening insurance contract liabilities |
3,083,652 | 61,561 | 2,486,425 | 97,512 | 5,729,150 |
Insurance revenue | (13,917,361) | – | – | – | (13,917,361) |
Insurance service expenses |
|||||
Incurred claims and other directly attributable expenses |
– | – | 13,001,338 | 111,151 | 13,112,489 |
Losses on onerous contracts |
– | – | – | – | – |
Changes that relate to past service - adjustments to the LIC |
– | – | (268,952) | (88,039) | (356,991) |
Reversal of onerous contract |
– | (61,561) | – | – | (61,561) |
Insurance acquisition cash flows amortization |
638,054 | – | – | – | 638,054 |
Insurance service expenses |
638,054 | (61,561) | 12,732,386 | 23,112 | 13,331,991 |
Insurance service result |
(13,279,307) | (61,561) | 12,732,386 | 23,112 | (585,370) |
Cash flows | |||||
Premiums received | 14,710,090 | – | – | – | 14,710,090 |
Claims and other directly attributable expenses paid |
– | – | (12,035,863) | – | (12,035,863) |
Insurance acquisition cash flows paid | (720,987) | – | – | – | (720,987) |
Total cash flows | 13,989,103 | – | (12,035,863) | – | 1,953,240 |
Closing insurance contract liabilities |
3,793,448 | – | 3,182,948 | 120,624 | 7,097,020 |
b. SMEs and others
2023 (SR ’000) | |||||
Liability for remaining co verage (LRC) | Liability for incurred claims (LIC) | ||||
Excluding
loss component |
Loss
component |
Estimate of
pr esent value o f cash flows |
RA for
no n-financial risk |
Total | |
Insurance contracts issued: | |||||
Opening insurance contract liabilities |
602,662 | – | 354,862 | 12,511 | 970,035 |
Insurance revenue | (1,970,354) | – | – | – | (1,970,354) |
Insurance service expenses |
|||||
Incurred claims and other directly attributable expenses |
– | – | 1,612,229 | 13,111 | 1,625,340 |
Losses on onerous contracts |
– | – | – | – | – |
Changes that relate to past service - adjustments to the LIC |
– | – | (60,042) | (11,479) | (71,521) |
Reversal of onerous contract |
– | – | – | – | – |
Insurance acquisition cash flows amortization |
108,622 | – | – | – | 108,622 |
Insurance service expenses |
108,622 | – | 1,552,187 | 1,632 | 1,662,441 |
Insurance service result |
(1,861,732) | – | 1,552,187 | 1,632 | (307,913) |
Cash flows | |||||
Premiums received | 2,103,653 | – | – | – | 2,103,653 |
Claims and other directly attributable expenses paid |
– | – | (1,469,798) | – | (1,469,798) |
Insurance acquisition cash flows paid | (125,801) | – | – | – | (125,801) |
Total cash flows | 1,977,852 | – | (1,469,798) | – | 508,054 |
Closing insurance contract liabilities |
718,782 | – | 437,251 | 14,143 | 1,170,176 |
a. Corporate
2022 (SR ’000) | |||||
Liability for remaining coverage (LRC) | Liability for incurred claims (LIC) | ||||
Excluding
loss component |
Loss
component |
Estimate of
present value of cash flows |
RA for
non-financial risk |
Total | |
Insurance contracts issued: | |||||
Opening insurance contract liabilities |
2,577,740 | 80,432 | 2,128,730 | 82,099 | 4,869,001 |
Insurance revenue | (11,263,622) | – | – | – | (11,263,622) |
Insurance service expenses |
|||||
Incurred claims and other directly attributable expenses |
– | – | 10,651,423 | 95,222 | 10,746,645 |
Losses on onerous contracts and reversal of those losses |
– | (18,871) | – | – | (18,871) |
Changes that relate to past service - adjustments to the LIC |
– | – | (348,810) | (79,809) | (428,619) |
Insurance acquisition cash flows amortization |
490,636 | – | – | – | 490,636 |
Insurance service expenses |
490,636 | (18,871) | 10,302,613 | 15,413 | 10,789,791 |
Insurance service result |
(10,772,986) | (18,871) | 10,302,613 | 15,413 | (473,831) |
Cash flows | |||||
Premiums received | 11,818,974 | – | – | – | 11,818,974 |
Claims and other directly attributable expenses paid |
– | – | (9,944,918) | – | (9,944,918) |
Insurance acquisition cash flows paid | (540,076) | – | – | – | (540,076) |
Total cash flows | 11,278,898 | – | (9,944,918) | – | 1,333,980 |
Closing insurance contract liabilities |
3,083,652 | 61,561 | 2,486,425 | 97,512 | 5,729,150 |
b. SMEs and others
2022 (SR ’000) | |||||
Liability for remaining coverage (LRC) | Liability for incurred claims (LIC) | ||||
Excluding
loss component |
Loss
component |
Estimate of
present value of cash flows |
RA for
non-financial risk |
Total | |
Insurance contracts issued: | |||||
Opening insurance contract liabilities |
515,330 | – | 202,760 | 7,254 | 725,344 |
Insurance revenue | (1,609,489) | – | – | – | (1,609,489) |
Insurance service expenses |
|||||
Incurred claims and other directly attributable expenses |
– | – | 1,335,956 | 12,249 | 1,348,205 |
Losses on onerous contracts and reversal of those losses |
– | – | – | – | – |
Changes that relate to past service - adjustments to the LIC |
– | – | (12,491) | (6,992) | (19,483) |
Insurance acquisition cash flows amortization |
87,520 | – | – | – | 87,520 |
Insurance service expenses |
87,520 | – | 1,323,465 | 5,257 | 1,416,242 |
Insurance service result |
(1,521,969) | – | 1,323,465 | 5,257 | (193,247) |
Cash flows | |||||
Premiums received | 1,707,240 | – | – | – | 1,707,240 |
Claims and other directly attributable expenses paid |
– | – | (1,171,363) | – | (1,171,363) |
Insurance acquisition cash flows paid | (97,939) | – | – | – | (97,939) |
Total cash flows | 1,609,301 | – | (1,171,363) | – | 437,938 |
Closing insurance contract liabilities |
602,662 | – | 354,862 | 12,511 | 970,035 |
7.2. Analysis by remaining coverage and incurred claims for reinsurance contracts
2023 (SR ’000) | |||||
Asset for remaini ng coverage | Asset for incu rred claims | ||||
Excluding
loss component |
Loss
recovery component |
Estimate of
pr esent value o f cash flows |
RA for
no n-financial risk |
Total | |
Reinsurance contracts held: | |||||
Opening reinsurance contract assets |
(2,669) | – | (24,585) | (901) | (28,155) |
Opening reinsurance contract liabilities |
2,605 | – | – | – | 2,605 |
Net opening balance | (64) | – | (24,585) | (901) | (25,550) |
Reinsurance expense | 151,740 | – | – | – | 151,740 |
Claims recovered and other directly attributable expenses |
– | – | (131,077) | (1,740) | (132,817) |
Changes that relate to past service - adjustments to the asset for incurred claims |
– | – | 8,903 | 420 | 9,323 |
Net expense from reinsurance contracts held |
151,740 | – | (122,174) | (1,320) | 28,246 |
Cash flows | |||||
Premiums ceded | (173,061) | – | – | – | (173,061) |
Recoveries from reinsurance | – | – | 96,275 | – | 96,275 |
Total cash flows | (173,061) | – | 96,275 | – | (76,786) |
Closing reinsurance contract assets |
(21,385) | – | (50,484) | (2,221) | (74,090) |
Closing reinsurance contract liabilities | – | – | – | – | – |
Net closing balance | (21,385) | – | (50,484) | (2,221) | (74,090) |
2022 (SR ’000) | |||||
Asset for remaining coverage | Asset for incurred claims | ||||
Excluding
loss component |
Loss
recovery component |
Estimate of
present value of cash flows |
RA for
non-financial risk |
Total | |
Reinsurance contracts held: | |||||
Opening reinsurance contract assets |
(8,263) | – | (50,166) | (683) | (59,112) |
Opening reinsurance contract liabilities |
25,397 | – | – | – | 25,397 |
Net opening balance | 17,134 | – | (50,166) | (683) | (33,715) |
Reinsurance expense | 73,952 | – | – | – | 73,952 |
Claims recovered and other directly attributable expenses |
– | – | (59,001) | (887) | (59,888) |
Changes that relate to past service - adjustments to the asset for incurred claims |
– | – | 14,717 | 669 | 15,386 |
Net expense from reinsurance contracts held |
73,952 | – | (44,284) | (218) | 29,450 |
Cash flows | |||||
Premiums ceded | (91,150) | – | – | – | (91,150) |
Recoveries from reinsurance | – | – | 69,865 | – | 69,865 |
Total cash flows | (91,150) | – | 69,865 | – | (21,285) |
Closing reinsurance contract assets |
(2,669) | – | (24,585) | (901) | (28,155) |
Closing reinsurance contract liabilities | 2,605 | – | – | – | 2,605 |
Net closing balance | (64) | – | (24,585) | (901) | (25,550) |
8. Investments
2023 (SR ’000) | 2022 (SR ’000) | 1 January 2022 (SR ’000) | |||||||
Insurance
operations |
Sh
areholders’
operations |
Total | Insurance
operations |
Shareholders’
operations |
Total | Insurance
operations |
Shareholders’
operations |
Total | |
Financial assets at amortised cost, net | 294,764 | 292,596 | 587,360 | 252,279 | 273,909 | 526,188 | 100,718 | 232,848 | 333,566 |
Financial assets at fair value | 1,947,087 | 2,299,670 | 4,246,757 | 1,033,101 | 1,819,133 | 2,852,234 | 2,499,429 | 2,873,094 | 5,372,523 |
2,241,851 | 2,592,266 | 4,834,117 | 1,285,380 | 2,093,042 | 3,378,422 | 2,600,147 | 3,105,942 | 5,706,089 |
Details of investments classified as financial assets at fair value are as follows:
2023 (SR ’000) | 2022 (SR ’000) | 1 January 2022 (SR ’000) | |||||||
Insurance
operations |
Sh
areholders’
operations |
Total | Insurance
operations |
Shareholders’
operations |
Total | Insurance
operations |
Shareholders’
operations |
Total | |
Investments at FVTPL | 46,361 | 422,328 | 468,689 | 132,543 | 345,164 | 477,707 | 1,844,958 | 1,865,797 | 3,710,755 |
Investments at FVOCI – Equity | – | 522,405 | 522,405 | – | 439,487 | 439,487 | – | 409,068 | 409,068 |
Investments at FVOCI – Debt | 1,900,726 | 1,354,937 | 3,255,663 | 900,558 | 1,034,482 | 1,935,040 | 654,471 | 598,229 | 1,252,700 |
1,947,087 | 2,299,670 | 4,246,757 | 1,033,101 | 1,819,133 | 2,852,234 | 2,499,429 | 2,873,094 | 5,372,523 |
(i) Investments measured at FVTPL comprise of the following:
2023 (SR ’000) | 2022 (SR ’000) | 1 January 2022 (SR ’000) | |||||||
Insurance
operations |
Sh
areholders’
operations |
Total | Insurance
operations |
Shareholders’
operations |
Total | Insurance
operations |
Shareholders’
operations |
Total | |
Sukuks | 11,014 | 36,044 | 47,058 | 11,014 | 36,044 | 47,058 | 18,014 | 55,044 | 73,058 |
Funds | 35,347 | 376,298 | 411,645 | 121,529 | 292,560 | 414,089 | 1,826,944 | 1,539,624 | 3,366,568 |
Equity | – | 9,986 | 9,986 | – | 16,560 | 16,560 | – | 271,129 | 271,129 |
46,361 | 422,328 | 468,689 | 132,543 | 345,164 | 477,707 | 1,844,958 | 1,865,797 | 3,710,755 |
(ii) Investments at FVOCI – Debt comprise of the following:
2023 (SR ’000) | 2022 (SR ’000) | 1 January 2022 (SR ’000) | |||||||
Insurance
operations |
Sh
areholders’
operations |
Total | Insurance
operations |
Shareholders’
operations |
Total | Insurance
operations |
Shareholders’
operations |
Total | |
Sukuks | 1,900,726 | 1,354,937 | 3,255,663 | 900,558 | 1,034,482 | 1,935,040 | 654,471 | 598,229 | 1,252,700 |
1,900,726 | 1,354,937 | 3,255,663 | 900,558 | 1,034,482 | 1,935,040 | 654,471 | 598,229 | 1,252,700 |
(iii) Investments at FVOCI – Equity comprise of the following:
2023 (SR ’000) | 2022 (SR ’000) | 1 January 2022 (SR ’000) | |||||||
Insurance
operations |
Sh
areholders’
operations |
Total | Insurance
operations |
Shareholders’
operations |
Total | Insurance
operations |
Shareholders’
operations |
Total | |
Equity | – | 58,774 | 58,774 | – | 52,481 | 52,481 | – | 58,070 | 58,070 |
Sukuks | – | 410,444 | 410,444 | – | 343,764 | 343,764 | – | 300,809 | 300,809 |
Investments in discretionary portfolios | – | 53,187 | 53,187 | – | 43,242 | 43,242 | – | 50,189 | 50,189 |
– | 522,405 | 522,405 | – | 439,487 | 439,487 | – | 409,068 | 409,068 |
(iv) Investments at amortized cost comprise of the following:
2023 (SR ’000) | 2022 (SR ’000) | 1 January 2022 (SR ’000) | |||||||
Insurance
operations |
Sh
areholders’
operations |
Total | Insurance
operations |
Shareholders’
operations |
Total | Insurance
operations |
Shareholders’
operations |
Total | |
Sukuks | 294,843 | 292,678 | 587,521 | 252,344 | 273,982 | 526,326 | 100,736 | 232,890 | 333,626 |
Impairment allowance on investments at amortised cost | (79) | (82) | (161) | (65) | (73) | (138) | (18) | (42) | (60) |
294,764 | 292,596 | 587,360 | 252,279 | 273,909 | 526,188 | 100,718 | 232,848 | 333,566 |
The movements in the investments, excluding loss allowance, are as follows:
2023 (SR ’000) | 2022 (SR ’000) | |||||
Insurance
operations |
Sh
areholders’
operations |
Total | Insurance
operations |
Shareholders’
operations |
Total | |
Balance at the beginning of the year | 1,285,445 | 2,093,115 | 3,378,560 | 2,600,165 | 3,105,984 | 5,706,149 |
Purchased during the year | 1,669,634 | 753,008 | 2,422,642 | 4,482,471 | 4,383,346 | 8,865,817 |
Disposed during the year | (765,380) | (295,242) | (1,060,622) | (5,777,805) | (5,412,545) | (11,190,350) |
Unrealized gains / (losses) during the year, net | 49,361 | 39,303 | 88,664 | (21,730) | 14,416 | (7,314) |
Accrued interest | 2,870 | 2,164 | 5,034 | 2,344 | 1,914 | 4,258 |
2,241,930 | 2,592,348 | 4,834,278 | 1,285,445 | 2,093,115 | 3,378,560 |
Movement in loss allowance for investments at amortised cost and FVOCI debt instruments for the year is as follows:
2023 (SR ’000) | 2022 (SR ’000) | |||||||
Stage 1
12-month ECL |
Stage 2 ECL
not Credit impaired |
Stage 3
Lifetime ECL cre dit impaired |
Total | Stage 1
12-month ECL |
Stage 2 ECL
not Credit impaired |
Stage 3
Lifetime ECL credit impaired |
Total | |
Balance at the beginning of the year | 138 | – | – | 138 | 60 | – | – | 60 |
Charge during the year | 23 | – | – | 23 | 78 | – | – | 78 |
161 | – | – | 161 | 138 | – | – | 138 |
Details on investment income for the year are as follows:
2023 (SR ’000) | 2022 (SR ’000) | |||||
Insurance
operations |
Sh
areholders’
operations |
Total | Insurance
operations |
Shareholders’
operations |
Total | |
Income on financial assets at fair value | ||||||
Commission income on investments at fair value | 58,614 | 73,764 | 132,378 | 24,290 | 38,753 | 63,043 |
Dividend income on investments at fair value | 2,473 | 27,216 | 29,689 | 7,143 | 34,483 | 41,626 |
Gains / (losses) on investments at fair value | 11,542 | (10,184) | 1,358 | 20,223 | 261,730 | 281,953 |
72,629 | 90,796 | 163,425 | 51,656 | 334,966 | 386,622 | |
Income on financial assets at amortised cost and term deposits | ||||||
Commission income on investments at amortized cost | 233,985 | 116,423 | 350,408 | 103,241 | 63,804 | 167,045 |
Gains on investments at amortized cost | – | 228 | 228 | – | 152 | 152 |
233,985 | 116,651 | 350,636 | 103,241 | 63,956 | 167,197 | |
306,614 | 207,447 | 514,061 | 154,897 | 398,922 | 553,819 |
9. Term deposits
The term deposits are held with reputable commercial banks and financial institutions. These deposits are predominately in Murabaha structure with a small allocation in Mudaraba structure. They are mostly denominated in Saudi Arabian Riyals and have an original maturity from more than three-month to more than one year and yield financial income at rates ranging from 1.55% to 6.40% per annum (2022: 1.10% to 5.85% per annum). The movements in term deposits during the year ended 31 December 2023 as follows:
2023 (SR ’000) | |||
Insurance
operations |
Sh
areholders’
operations |
Total | |
Balance at the beginning of the year before loss allowance | 4,753,100 | 1,655,389 | 6,408,489 |
Placed during the year | 3,534,871 | 800,000 | 4,334,871 |
Matured during the year | (3,127,255) | (677,545) | (3,804,800) |
Commission income earned during the year | 197,712 | 88,700 | 286,412 |
Less: loss allowance | (1,460) | (501) | (1,961) |
5,356,968 | 1,866,043 | 7,223,011 |
2022 (SR ’000) | |||
Insurance
operations |
Shareholders’
operations |
Total | |
Balance at the beginning of the year before loss allowance | 2,007,922 | 1,085,798 | 3,093,720 |
Placed during the year | 4,795,854 | 1,415,869 | 6,211,723 |
Matured during the year | (2,153,669) | (883,814) | (3,037,483) |
Commission income earned during the year | 102,993 | 37,536 | 140,529 |
Less: loss allowance | (1,217) | (424) | (1,641) |
4,751,883 | 1,654,965 | 6,406,848 |
Movement in loss allowance for term deposits for the year is as follows:
2023 (SR ’000) | |||
Insurance
operations |
Sh
areholders’
operations |
Total | |
Balance at the beginning of the year | 1,217 | 424 | 1,641 |
Provision made during the year | 243 | 77 | 320 |
Balance at end of the year | 1,460 | 501 | 1,961 |
2022 (SR ’000) | |||
Insurance
operations |
Shareholders’
operations |
Total | |
Balance at the beginning of the year | 362 | 195 | 557 |
Provision made during the year | 855 | 229 | 1,084 |
Balance at end of the year | 1,217 | 424 | 1,641 |
10. Fixtures, furniture and equipment & right of use assets
10.1. Fixtures, Furniture and Equipment
2023 (SR ’000) | ||||||
Office,
furniture, and fixtures |
Computer
equipment |
Motor
vehicles |
Leasehold
improvements |
Capital
work in progress |
Total | |
Cost: | ||||||
At 1 January 2023 | 87,538 | 69,056 | 404 | 40,900 | 7,021 | 204,919 |
Additions during the year | 39 | 21 | – | – | 22,345 | 22,405 |
Transferred during the year | 1,639 | 4,591 | – | 19,331 | (25,561) | – |
Disposals during the year | (161) | (9,676) | – | – | – | (9,837) |
At 31 December 2023 |
89,055 | 63,992 | 404 | 60,231 | 3,805 | 217,487 |
Accumulated depreciation: | ||||||
At 1 January 2023 | (72,924) | (52,070) | (363) | (15,919) | – | (141,276) |
Charge for the year | (4,424) | (6,396) | (41) | (5,308) | – | (16,169) |
Disposal during the year | 161 | 9,676 | – | – | – | 9,837 |
At 31 December 2023 | (77,187) | (48,790) | (404) | (21,227) | – | (147,608) |
Net book value: | ||||||
At 31 December 2023 | 11,868 | 15,202 | – | 39,004 | 3,805 | 69,879 |
2022 (SR ’000) | ||||||
Office,
furniture, and fixtures |
Computer
equipment |
Motor
vehicles |
Leasehold
improvements |
Capital
work in progress |
Total | |
Cost: | ||||||
At 1 January 2022 | 87,050 | 67,380 | 404 | 39,435 | 2,472 | 196,741 |
Additions during the year | – | 11 | – | – | 9,891 | 9,902 |
Transferred during the year | 805 | 3,072 | – | 1,465 | (5,342) | – |
Disposals during the year | (317) | (1,407) | – | – | – | (1,724) |
At 31 December 2022 | 87,538 | 69,056 | 404 | 40,900 | 7,021 | 204,919 |
Accumulated depreciation: | ||||||
At 1 January 2022 | (68,221) | (46,490) | (262) | (11,997) | – | (126,970) |
Charge for the year | (4,905) | (6,806) | (101) | (3,922) | – | (15,734) |
Disposal during the year | 202 | 1,226 | – | – | – | 1,428 |
At 31 December 2022 | (72,924) | (52,070) | (363) | (15,919) | – | (141,276) |
Net book value: | ||||||
At 31 December 2022 | 14,614 | 16,986 | 41 | 24,981 | 7,021 | 63,643 |
10.2. Right-of-Use Assets
The movement of right-of-use assets, which mainly include buildings are as follows:
2023
SR ’000 |
2022
SR ’000 |
|
At 1 January | 165,947 | 112,616 |
Additions during the year | – | 74,350 |
Amortisation during the year | (22,559) | (21,019) |
At 31 December | 143,388 | 165,947 |
The Company leases various buildings for offices. Rental contracts are typically made for one year with extension options. There is no non-lease components in the contracts. The lease agreements do not impose any covenants other than the security interests in the leased assets that are held by the lessor. Leased assets may not be used as security for borrowing purposes.
In determining the lease term, management considers all facts and circumstances that create an economic incentive to exercise an extension option, or not exercise a termination option. For leases of office buildings, management concluded that it was reasonably certain to extend the lease beyond 1 year, taking into account the leasehold improvements in the premises, historical lease durations and the costs and business disruption required to change premises.
11. Intangible assets
2023 (SR ’000) | |||
Software | Capi
tal work-in-
progress |
Total | |
Cost: | |||
At 1 January 2023 | 179,209 | 9,819 | 189,028 |
Additions during the year | 2,377 | 16,475 | 18,852 |
Transfers during the year | 8,197 | (8,197) | – |
Disposals during the year | (352) | – | (352) |
At 31 December 2023 | 189,431 | 18,097 | 207,528 |
Accumulated amortisation: | |||
At 1 January 2023 | (123,615) | – | (123,615) |
Charge for the year | (17,029) | – | (17,029) |
Disposals during the year | 352 | – | 352 |
At 31 December 2023 | (140,292) | – | (140,292) |
Net book value: | |||
At 31 December 2023 | 49,139 | 18,097 | 67,236 |
2022 (SR ’000) | |||
Software | Capital work-in-
progress |
Total | |
Cost: | |||
At 01 January 2022 | 152,540 | 25,247 | 177,787 |
Additions during the year | 81 | 11,486 | 11,567 |
Transfers during the year | 26,914 | (26,914) | – |
Disposals during the year | (326) | – | (326) |
At 31 December 2022 | 179,209 | 9,819 | 189,028 |
Accumulated amortization: | |||
At 01 January 2022 | (110,510) | – | (110,510) |
Charge for the year | (13,105) | – | (13,105) |
At 31 December 2022 | (123,615) | – | (123,615) |
Net book value: | |||
At 31 December 2022 | 55,594 | 9,819 | 65,413 |
12. Prepaid expenses and other assets
Prepaid expenses and other assets comprise of the following
2023 (SR ’000) | 2022 (SR ’000) | |||||
Insurance
operations |
Sh
areholders’
operations |
Total | Insurance
operations |
Shareholders’
operations |
Total | |
VAT receivables | 335,302 | – | 335,302 | 271,778 | – | 271,778 |
Prepaid expenses | 79,133 | – | 79,133 | 56,515 | – | 56,515 |
Fee receivable | – | 17,548 | 17,548 | – | 53,164 | 53,164 |
Accrued income | 18,171 | 15,950 | 34,121 | 9,107 | 12,844 | 21,951 |
Other receivables | 6,777 | 2,594 | 9,371 | 6,890 | 221 | 7,111 |
439,383 | 36,092 | 475,475 | 344,290 | 66,229 | 410,519 |
13. Statutory deposit
As required by SAMA Insurance Regulations, the Group deposited an amount equivalent to 10% of its paid-up share capital, amounting to SR 150 million, in a bank designated by SAMA. Accrued income on this deposit is payable to Insurance Authority amounting to SR 8.69 million (31 December 2022: SR 16.24 million and 1 January 2022: SR14.89 million) and this deposit cannot be withdrawn without approval from SAMA. As requested by SAMA, the Group has released the accrued income on statutory deposit to SAMA up to 31 December 2022 amounting to SR 16.24 million. The statutory deposit is shown on the statement of financial position net of impairment allowance.
14. Fiduciary assets
During the year ended 31 December 2018, after obtaining SAMA’s approvals, the Group entered into a Third-Party Administration agreement (TPA) with a customer under which the Group facilitates healthcare services to Customer’s employees with specific terms and conditions. The agreement is effective from 1 March 2018. The services are remunerated against administration fees.
In order to fulfil the commitment relating to this agreement, the Group receives funds in advance from the customer to settle anticipated claims from medical service providers. As the Group acts as an agent, the relevant bank balance and related payables at the reporting date, are excluded from the consolidated statement of financial position. The assets and liabilities held in fiduciary capacity amounted to SR 424 million as of 31 December 2023
(31 December 2022: SR 259 million and
31 December 2021: SR 260 million).
15. Commitments and contingencies
- The Group is subject to legal proceedings in the ordinary course of business. There was no material change in the status of legal proceedings as of 31 December 2023.
- As of 31 December 2023, total letters of guarantee issued by banks amounted to SR 161 million
(31 December 2022: SR 140 million). - Refer to Note 22 for zakat and tax related matters.
The Group’s commitments and contingencies are as follows:
16. Accrued and other liabilities and lease liability
16.1. Accrued and other liabilities comprise of the following:
2023 (SR ’000) |
2022 (SR ’000) |
|||||
Insurance operations | Shareholders’ operations | Total | Insurance operations | Shareholders’ operations | Total | |
VAT payable | 178,784 | – | 178,784 | 116,159 | – | 116,159 |
VAT payable to providers | 472,518 | – | 472,518 | 356,059 | – | 356,059 |
Accrued expenses |
34,944 | 11,085 | 46,029 | 26,588 | 9,199 | 35,787 |
Other liabilities | 37,528 | – | 37,528 | 22,710 | – | 22,710 |
723,774 | 11,085 | 734,859 | 521,516 | 9,199 | 530,715 |
16.2. Lease liability
As of 31 December 2023, lease liability amounted SR 166 million (2022: SR 184.7 million). Below is the movement during the year:
2023 SR ’000 |
2022 SR ’000 |
|
Balance at the beginning of the year | 184,682 | 125,333 |
Finance cost | 6,065 | 6,287 |
Additions during the year | – | 74,350 |
Lease payments (total cash outflows) | (24,681) | (21,288) |
166,066 | 184,682 |
17. Trademark fees
During 2010, the Group entered into an agreement with a related party for obtaining a license to use the trademark (the word Bupa with or without logo) of the related party. As per the terms of the agreement, the trademark fee is payable at different rates linked to the results of the Group, subject to a maximum of threshold. Accordingly, a sum of SR 39.2 million (2022: SR 32.1 million) payable to a related party has been accrued for during the year (see Notes 21 and 26).
18. Employees’ end of service benefits
Accruals are made in accordance with the actuarial valuation under the projected unit credit method while the benefit payments obligation is discharged as and when it falls due. The amounts recognised in the statement of financial position and movement in the obligation during the year based on its present value are as follows:
18.1. Movement of end-of-service benefits
2023 SR ’000 |
2022 SR ’000 |
|
Balance at the beginning of the year | 154,054 | 152,286 |
Consolidated statement of income | ||
Current service costs | 24,552 | 21,940 |
Finance costs | 7,012 | 3,859 |
Consolidated statement of comprehensive income | ||
Actuarial losses/(gains) | 6,655 | (16,595) |
Cash movement | ||
Benefits paid during the year | (5,786) | (7,436) |
Balance at the end of the year | 186,487 | 154,054 |
18.2. Principal actuarial assumptions
The following range of significant actuarial assumptions was used by the Group for the valuation of end-of-service benefits:
2023 % |
2022 % |
|
Valuation discount rate | 4.75 | 4.70 |
Expected rate of increase in salary level across different age bands | 4.50 | 4.50 |
Employee turnover rate | 8.95 | 10.5 |
Mortality rate | 0.06 | 0.06 |
The impact of changes in sensitivities on present value of employees’ end-of-service (Increase)/Decrease) benefits is as follows:
2023 SR ’000 |
2022 SR ’000 |
|
Valuation discount rate | ||
– Increase by 0.5% | 7,265 | 6,130 |
– Decrease by 0.5% | (7,774) | (6,568) |
Expected rate of increase in salary level across different age bands | ||
– Increase by 1% | (16,048) | (13,554) |
– Decrease by 1% | 14,277 | 12,027 |
Mortality rate | ||
– Increase by 50% | (48) | (35) |
– Decrease by 50% | 49 | 35 |
Employee turnover | ||
– Increase by 20% | 1,408 | 1,430 |
– Decrease by 20% | (1,320) | (1,358) |
The average duration of the employees’ end-of-service benefits at the end of the reporting period is 9.2 years (2022: 9.4 years). The total expected payments of the liability, undiscounted, amount to SR 258 million (2022: SR 215 million) out of which SR 24.2 million (2022: SR 20.3 million) are expected to be paid within the next 12 months.
19. Fair value of financial instruments
Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value measurement is based on the presumption that the transaction takes place either:
- in the accessible principal market for the asset or liability, or
- in the absence of a principal market, in the most advantageous accessible market for the asset or liability.
a) Determination of fair value and fair value hierarchy
The Group uses the following hierarchy for determining and disclosing the fair value of financial instruments:
Level 1: quoted prices in active markets for the same or identical instrument that an entity can access at the measurement date.
Level 2: quoted prices in active markets for similar assets and liabilities or other valuation techniques for which all significant inputs are based on observable market data; and
Level 3: valuation techniques for which any significant input is not based on observable market data.
b) Carrying amounts and fair value
The following table shows the carrying amount and fair value of financial assets and financial liabilities, including their levels in the fair value hierarchy for financial instruments measured at fair value. It does not include fair value information for financial assets and financial liabilities not measured at fair value (financial assets and liabilities at amortised cost) as the carrying amount is a reasonable approximation to fair value.
31 December 2023 | Fair value | ||||
Level 1 | Level 2 | Level 3 | Total | Carrying value | |
Financial assets measured at fair value: | |||||
– Investment at FVTPL | 17,194 | 392,780 | 58,715 | 468,689 | 468,689 |
– Investment at FVOCI – Debt | 2,733,619 | 522,044 | – | 3,255,663 | 3,255,663 |
– Investment at FVOCI – Equity | 522,405 | – | – | 522,405 | 522,405 |
3,273,218 | 914,824 | 58,715 | 4,246,757 | 4,246,757 |
31 December 2022 | Fair value | ||||
Level 1 | Level 2 | Level 3 | Total | Carrying value | |
Financial assets measured at fair value: | |||||
– Investment at FVTPL | 15,823 | 390,752 | 71,132 | 477,707 | 477,707 |
– Investment at FVOCI – Debt | 1,331,957 | 603,083 | – | 1,935,040 | 1,935,040 |
– Investment at FVOCI – Equity | 439,487 | – | – | 439,487 | 439,487 |
1,787,267 | 993,835 | 71,132 | 2,852,234 | 2,852,234 |
1 January 2022 | Fair value | ||||
Level 1 | Level 2 | Level 3 | Total | Carrying value | |
Financial assets measured at fair value: | |||||
– Investment at FVTPL | 284,668 | 3,403,964 | 22,123 | 3,710,755 | 3,710,755 |
– Investment at FVOCI – Debt | 607,067 | 645,633 | – | 1,252,700 | 1,252,700 |
– Investment at FVOCI – Equity | 409,068 | – | – | 409,068 | 409,068 |
1,300,803 | 4,049,597 | 22,123 | 5,372,523 | 5,372,523 |
c) Measurement of fair value
Valuation technique and significant unobservable inputs
The following table shows the valuation techniques used in measuring Level 3 fair value at 31 December 2023 and 31 December 2022, as well as the significant unobservable inputs used. The fair value used for valuation of Level 2 Sukuks and mutual funds are based on prices quoted on reliable and third-party sources including Reuters, Bloomberg, etc. Management believes that the fair values of the Company’s financial assets and liabilities as at 31 December 2023 are not materially different from their carrying values since the financial instruments are short term in nature, carry profit rates which are based on prevailing market profit rates and are expected to be realised at their current carrying values within twelve months from the date of the statement of financial position.
Type | Valuation technique | Significant unobservable inputs |
Inter-relationship between significant unobservable inputs and fair value measurement |
Mutual funds | Mutual funds classified as Level 3 are fair valued based on the latest available NAV adjusted for the fair value which are not observable. | Fair value of underlying assets | The estimated fair value will increase/ decrease directly in line with the change in fair value of underlying assets. |
Movement of level 3 instruments:
2023
SR ’000 |
2022
SR ’000 |
|
Opening fair value | 71,132 | 22,123 |
Additions in level 3 investments | – | 47,786 |
Disposals of level 3 investments | – | – |
Fair value gain/(loss) – net | (12,417) | 1,223 |
Closing fair value | 58,715 | 71,132 |
The impact of change in net assets value reported in level 3 on net income and total equity is as follows:
2023
SR ’000 |
2022
SR ’000 |
|
+/- 5% change in net assets value | +/-2,936 | +/-3,557 |
20. Operating segments
The Group only issues short-term insurance contracts for providing health care services (‘medical insurance’). The Group operates as a mono-line insurer, operating in the Private Medical Insurance (PMI) business. All the insurance operations of the Group are carried out in the Kingdom of Saudi Arabia. For management reporting purposes, the operations are monitored in two groups that are Corporate and Small and Medium Enterprises and Others (SME and Others). Corporate segment/customer represents members of large corporations, and all others are considered as SME and Others. Operating segments are reported in a manner consistent with internal reporting provided to the chief operating decision maker, who is responsible for allocating resources and assessing the performance of operating segments in line with the strategic decisions.
Operating segments do not include shareholders’ operations of the Group. Segment results do not include investment, other operating expenses, other revenues and other costs. Segment assets and liabilities only include the insurance and reinsurance contract liabilities and assets while the other accounts are not allocated. Consistent with the Group’s internal reporting, operating segments have been approved by the Management in respect of the Group’s activities, assets and liabilities as stated below:
2023 (SR ’000) |
|||
Corporate | SM E and others | Total | |
Operating segments | |||
Assets | |||
Asset for incurred claims | 52,705 | – | 52,705 |
Asset for remaining coverage | 21,385 | – | 21,385 |
Reinsurance contract assets | 74,090 | 74,090 | |
Unallocated assets | 14,364,261 | ||
Total assets | 14,438,351 | ||
Liabilities | |||
Liability for incurred claims | 3,303,572 | 451,394 | 3,754,966 |
Liability for remaining coverage | 3,793,448 | 718,782 | 4,512,230 |
Insurance contract liabilities | 7,097,020 | 1,170,176 | 8,267,196 |
Reinsurance contract liabilities | – | ||
Unallocated liabilities | 1,495,626 | ||
Total liabilities | 9,762,822 |
2022 (SR ’000) |
|||
Corporate | SME and others | Total | |
Operating segments | |||
Assets | |||
Asset for incurred claims | 25,486 | – | 25,486 |
Asset for remaining coverage | 2,669 | – | 2,669 |
Reinsurance contract assets | 28,155 | 28,155 | |
Unallocated assets | 12,086,776 | ||
Total assets | 12,114,931 | ||
Liabilities | |||
Liability for incurred claims | 2,583,938 | 367,373 | 2,951,311 |
Liability for remaining coverage | 3,145,212 | 602,662 | 3,747,874 |
Insurance contract liabilities | 5,729,150 | 970,035 | 6,699,185 |
Reinsurance contract liabilities | 2,605 | ||
Unallocated liabilities | 1,212,252 | ||
Total liabilities | 7,914,042 |
2022 (SR ’000) | |||
Corporate | SME and others | Total | |
Operating segments | |||
Assets | |||
Asset for incurred claims | 50,849 | – | 50,849 |
Asset for remaining coverage | 8,263 | – | 8,263 |
Reinsurance contract assets | 59,112 | 59,112 | |
Unallocated assets | 10,566,286 | ||
Total assets | 10,625,398 | ||
Liabilities | |||
Liability for incurred claims | 2,210,829 | 210,014 | 2,420,843 |
Liability for remaining coverage | 2,658,172 | 515,330 | 3,173,502 |
Insurance contract liabilities | 4,869,001 | 725,344 | 5,594,345 |
Reinsurance contract liabilities | 25,397 | ||
Unallocated liabilities | 845,685 | ||
Total liabilities | 6,465,427 |
2023 (SR ’000) |
2022 (SR ’000) |
|||||
Corporate | SM E and others | Total | Corporate | SME & Others | Total | |
Insurance revenue | 13,917,361 | 1,970,354 | 15,887,715 | 11,263,622 | 1,609,489 | 12,873,111 |
Insurance service expense | (13,331,991) | (1,662,441) | (14,994,432) | (10,789,791) | (1,416,242) | (12,206,033) |
Net expenses from reinsurance contracts held | (28,246) | – | (28,246) | (29,450) | – | (29,450) |
Net insurance service result | 557,124 | 307,913 | 865,037 | 444,381 | 193,247 | 637,628 |
Investment income on financial assets at amortised cost | 350,636 | 167,197 | ||||
Investment income on financial assets at fair value | 163,425 | 386,622 | ||||
Net impairment loss on financial assets | (785) | (1,685) | ||||
Net insurance and investment results | 1,378,313 | 1,189,762 | ||||
Other operating expenses | (316,813) | (246,854) | ||||
Other revenue | 92,065 | 42,633 | ||||
Other costs | (36,886) | (16,378) | ||||
Income attributed to the shareholders before zakat and income tax | 1,116,679 | 969,163 | ||||
Zakat charge | (80,237) | (72,938) | ||||
Income tax charge | (96,279) | (91,108) | ||||
Net income attributed to shareholders after zakat and income tax | 940,163 | 805,117 |
The details of gross written premium are as follows:
2023 SR ’000 |
2022 SR ’000 |
|
Corporates | 12,452,048 | 10,252,338 |
Medium enterprises | 2,946,431 | 2,543,347 |
Small enterprises | 1,092,783 | 941,027 |
Micro enterprises | 135,276 | 118,231 |
Individuals | 42,206 | 41,940 |
16,668,744 | 13,896,883 |
21. Related parties transactions and balances
Related parties represent major shareholders, Board members and key management personnel of the Group, and companies of which they are principal owners and any other entities controlled, jointly controlled or significantly influenced by them. Other related parties represent entities under common control and entities controlled by key management personnel of the Company. Contract pricing policies and terms are approved by the Group’s management or where required and applicable the Group’s Board of Directors. The due from and to balances of related parties are unsecured, interest free and repayable in cash on demand. Key management personnel are those persons, including executive directors, having authority and responsibility for planning, directing and controlling the activities of the Group, directly or indirectly. The following are the details of the major related party transactions during the period and their related balances:
Related party | Nature of transaction | Amount of transactions during the year ended income/(expense) |
Receivable/(payable) balance as at |
||
2023
SR ’000 |
2022
SR ’000 |
2023
SR ’000 |
2022
SR ’000 |
||
Balances included in insurance contract liabilities | |||||
Shareholders and other related parties* | Premium issued | 505,412 | 231,255 | 13,882 | 607 |
Shareholders and other related parties* | Claims incurred | (447,706) | (148,628) | (21,055) | (17,725) |
Shareholders | Medical costs charged by providers | (288,064) | (205,554) | (20,418) | (41,925) |
(27,591) | (59,043) | ||||
Balances included in reinsurance contract assets | |||||
Shareholders | Reinsurance Premium ceded | (175,533) | (93,406) | (50,674) | (45,596) |
Balances included in due (to)/from Related Parties | |||||
Shareholders | Expenses recharged (to)/from a related party-net | (1,720) | (2,068) | (788) | 2,200 |
Shareholders | Tax equalization – net | – | 68,431 | – | 33,913 |
Shareholders | Board and committee member remuneration fees | (920) | (915) | (920) | (703) |
Bupa Middle East Holdings Two W.L.L. (Affiliate) | Trademark fee | (39,227) | (32,094) | (39,227) | (32,094) |
(40,935) | 3,316 |
* During the year ended 31 December 2023, premium issued related to shareholders amounts to SR 0.87 million (2022: SR 1.19 million) and claims paid related to shareholders amounts to SR 0.61 million (2022: SR 0.80 million).
* During the year ended 31 December 2023, premium issued related to board members and key management personnel of the Group, and companies of which they are principal owners and any other
entities controlled, jointly controlled or significantly influenced by them amounts to SR 505.54 million (2022: SR 230.06 million) and claims paid related to such entities amounts to SR 447.10 million
(2022: SR 147.83 million).
a. Compensation to key management personnel
2023
SR ’000 |
2022
SR ’000 |
|
Short-term benefits | 42,284 | 29,245 |
Long-term benefits | 1,949 | 1,455 |
Share based payment transactions | 14,942 | 14,222 |
59,175 | 44,922 |
Short-term benefits include salaries, allowances, annual bonuses and incentives whilst long-term benefits include employees’ end of service benefits.
b. Board of Directors’ remuneration and related expenses
2023
SR ’000 |
2022
SR ’000 |
|
Board of directors’ remuneration | 3,800 | 3,700 |
Board attendance fees | 457 | 518 |
Other board and sub-committees expenses | 1,944 | 1,514 |
6,201 | 5,732 |
22. Zakat and income tax
Breakup of zakat and income tax charge for the year ended 31 December 2023 and 2022 are as follows:
Notes
|
2023
SR ’000 |
2022
SR ’000 |
|
Current zakat charge | 80,237 | 72,938 | |
Current tax charge | 94,377 | 91,790 | |
Deferred tax charge | 22.a | 1,902 | (682) |
96,279 | 91,108 | ||
176,516 | 164,046 |
(a) The reconciliation of deferred tax is as follows:
2023
SR ’000 |
2022
SR ’000 |
|
Opening deferred tax asset | 40,511 | 39,829 |
Deferred tax (charge)/income | (1,902) | 682 |
38,609 | 40,511 |
The Group has recognised a deferred tax asset as it is probable that future taxable profits will be available and the credits can be utilised. The deferred tax arises mainly on provision for doubtful premium receivables and end of service benefits.
Movements in the zakat and income tax accrued during the year ended 31 December 2023 and year ended 31 December 2022 respectively are as follows:
Zakat
payable SR ’000 |
Income tax
payable SR ’000 |
Total
2023 SR ’000 |
|
Balance at beginning of the year | 264,583 | 61,983 | 326,566 |
Opening balance assumed through consolidation | – | – | – |
Provided during the year | 80,237 | 94,377 | 174,614 |
Payments during the year | (15,742) | (126,849) | (142,591) |
Balance at end of the year | 329,078 | 29,511 | 358,589 |
Zakat
payable |
Income tax
payable |
Total
2022 SR ’000 |
|
Balance at beginning of the year | 202,820 | 33,790 | 236,610 |
Opening balance assumed through consolidation | 70 | – | 70 |
Provided during the year | 72,938 | 91,790 | 164,728 |
Payments during the year | (11,245) | (63,597) | (74,842) |
Balance at end of the year | 264,583 | 61,983 | 326,566 |
Breakup of income tax for the year ended 31 December 2023 and 2022 are as follows:
2023
SR ’000 |
2022
SR ’000 |
|
Accounting profit before tax and zakat | 1,116,679 | 969,163 |
Less: Income subject to zakat | (633,715) | (550,000) |
Accounting profit for non-Saudi shareholders | 482,964 | 419,163 |
Tax effects of | ||
– Non-tax deductible expenses/reversal | (10,979) | 14,823 |
– IFRS 17 and IFRS 9 adoption impact | – | 24,963 |
– Prior year adjustments | (100) | – |
Adjusted profit/loss for tax base | 471,885 | 458,949 |
Corporate tax at 20% | 94,377 | 91,790 |
Status of assessments
Bupa Arabia For Cooperative Insurance Company
The Company has filed its zakat and income tax returns for the financial years up to and including the year 2022 with Zakat, Tax and Customs Authority (ZATCA).
The Company has finalized its zakat and income tax returns with ZATCA for the fiscal periods 2008 through 2016 and 2018. For the year 2017, the Company received an assessment amounting to SR 35.8 million in as additional zakat and tax liability, the Company has escalated the matter to the General Secretariat of Tax Committees (GSTC) with the Appeal Committee for Tax Violations and Disputes and awaits for the decision. Also, the Company has received the final assessment for the years 2019 and 2020 amounting to SR 36.7 million and SR 41 million, respectively. The Company has filed an appeal to the GSTC with the Resolution Committee for Tax Violations and Disputes and their review and the outcome of the appeal is awaited. The management believes that these assessments are appropriately provisioned.
The Company is yet to receive the final assessment for the years ended 31 December 2021 and 2022.
Bupa Arabia For Third Party Administration
The Company has filed its zakat and income tax returns for the financial years up to and including the year 2022 with ZATCA. The due zakat and tax under these years and these returns are still under ZATCA’s review.
23. Share capital
The authorised, issued and paid-up capital of the Group is SAR 1,500 million at 31 December 2023 (31 December 2022: SAR 1,500 million) consisting of 150 million shares (31 December 2022: 150 million shares) of SAR 10 each. Shareholding structure of the Group is as below:
2023 | 2022 | |||
Holding
pe rcentage (%) |
Amount
SR ’000 |
Holding
percentage (%) |
Amount
SR ’000 |
|
Major shareholders | 48.3 | 723,825 | 50.6 | 758,850 |
General Public | 51.7 | 776,175 | 49.4 | 741,150 |
100 | 1,500,000 | 100 | 1,500,000 |
The major shareholders of the Group along with their holding percentages are as below:
2023 | 2022 | |||
Holding
Pe rcentage (%) |
Amount
SR ’000 |
Holding
Percentage (%) |
Amount
SR ’000 |
|
Bupa Investment Overseas Limited | 43.3 | 648,750 | 43.3 | 648,750 |
Nazer Group Company Limited | 7.3 | 75,075 | 7.3 | 110,100 |
48.3 | 723,825 | 50.6 | 758,850 |
The total shareholders’ equity as of 31 December 2023 for Saudi shareholders is SR 2,663 million (31 December 2022: SR 2,396 million) and foreign shareholder is SR 1,994 million (31 December 2022: SR 1,826 million) after incorporating their respective shareholding percentage and impact of zakat, income tax, reimbursement and other adjustments. The above shareholders’ equity is arrived after allocating the net income after zakat of SR 554 million and net income after income tax of SR 387 million to Saudi and foreign shareholders, respectively. Retained earnings as of 31 December 2023 for Saudi shareholders is SR 1,072 million (2022: SR 932 million) and foreign shareholder is SR 782 million (2022: SR 710 million). Statutory reserve as of 31 December 2023 for Saudi shareholders is SR 768 million (2022: SR 661 million) and foreign shareholder is SR 585 million
(2022: SR 504 million).
On 2 May 2023, the Board of Directors of the Company has recommended a dividend of SR 3.6 per share for the year ended
31 December 2022 (SR 4.5 per share for the year ended 31 December 2021). The dividends were approved by the shareholders in the Extraordinary General Assembly meeting held on 22 June 2023 and paid subsequently.
24. Statutory reserve
As required by the Saudi Arabian Insurance Regulations, 20% of the shareholders’ income shall be set aside as a statutory reserve until this reserve amounts to 100% of the paid-up share capital. The Group carries out this transfer on an annual basis at 31 December. As at 31 December 2023, SR 1,353 million (31 December 2022: SR 1,165 million) had been set aside as a statutory reserve, equal to 90.2% (31 December 2022: 77.6%) of the paid-up share capital.
25. Share-based payments
The Group established a share-based compensation scheme for its key management that entitles them to Bupa Arabia shares subject to successfully meeting certain service and performance conditions. Under the share-based compensation scheme, the Group manages various plans. Significant features of these plans are as follows:
Maturity dates | Between March 2023 and March 2025 |
Total number of shares granted on the grant date | 738,838 (2021: 497,769) |
Vesting period | 3-4 years (2021: same) |
Method of settlement | Equity (2021: same) |
Fair value per share on grant date | Average SR 102.91 (2021: average SR 105.86) |
2023 | 2022 | |||
Average
price SR ’000 |
Number
of shares SR ’000 |
Average
price SR ’000 |
Number
of shares SR ’000 |
|
As at 1 January | 101.58 | 770,162 | 105.01 | 508,100 |
Granted during the year | 206.12 | 91,378 | 166.65 | 219,033 |
Delivered during the year | 87.20 | (366,470) | 104.71 | (111,003) |
Bonus Shares | – | – | – | 154,032 |
As at 31 December | 131.53 | 495,070 | 101.58 | 770,162 |
These shares are granted only under a service/performance condition with no market condition associated with them. Total amount of expense recognised in consolidated statement of income during the year ended December 31, 2023 in respect of this scheme was SR 26.1 million (2022: SR 22.3 million).
26. Other operating expenses
2023
SR ’000 |
2022
SR ’000 |
|
Policy acquisition cost | 746,676 | 578,156 |
Employees’ costs | 637,555 | 521,652 |
Income attributable to insurance operations | 97,004 | 65,303 |
Rents, IT and maintenance costs | 77,722 | 77,216 |
Legal and professional fees | 67,843 | 40,065 |
Depreciation and amortization | 55,759 | 49,859 |
Trademark fee | 39,227 | 32,094 |
Travelling and other expenses | 38,289 | 16,992 |
Marketing expenses | 35,460 | 33,084 |
Communication expenses | 14,924 | 12,458 |
Other expenses | 9,478 | 1,501 |
Total | 1,819,937 | 1,428,380 |
Allocation of expenses is as follows:
2023 (SR ’000) | 2022 (SR ’000) | |||||
Insurance
operations |
Sh
areholders’
operations |
Total | Insurance
operations |
Shareholders’
operations |
Total | |
Other attributable expenses* |
756,448 | – | 756,448 | 603,370 | – | 603,370 |
Policy acquisition cost* |
746,676 | – | 746,676 | 578,156 | – | 578,156 |
Other operating expenses** |
297,956 | 18,857 | 316,813 | 231,628 | 15,226 | 246,854 |
1,801,080 | 18,857 | 1,819,937 | 1,413,154 | 15,226 | 1,428,380 |
* Reported part of insurance service expense
** Other operating expenses include non-attributable expenses which are administrative expenses and are not linked to insurance contracts.
Other revenue from the subsidiary amounted to SR 92.065 million (2022: 42.633 million). The nature of “Other costs”, as disclosed on the statement of income primarily represents direct and indirect manpower cost, and any other expense. Other costs were incurred in the provision of claims management and handling services for a third party.
27. Capital management
Objectives are set by the Board of Directors of the Group to maintain healthy capital ratios to support its business objectives and maximise shareholders’ value.
As per guidelines laid out by SAMA in Article 66 of the Implementing Regulations of the Cooperative Insurance Companies Control Law detailing the solvency margin required to be maintained, the Company shall maintain solvency margin equivalent to the highest of the following three methods as per SAMA Implementing Regulations:
- Minimum Capital Requirement of SAR 200 million
- Premium Solvency Margin
- Claims Solvency Margin
The Group manages its capital requirements by assessing shortfalls between reported and required capital levels on a regular basis. Adjustments to current capital levels are made in light of changes in market conditions and the risk characteristics of the Group’s activities. To maintain or adjust the capital structure, the Group may adjust the amount of dividends paid to shareholders or issue shares. In the opinion of the Board of Directors, the Group has fully complied with the regulatory capital requirements during the reported financial period. As at 31 December 2023 the Company’s solvency level is higher than the minimum solvency margin required by the Implementing Regulations of the Cooperative Insurance Companies Control Law.
28. earnings per share
The basic and diluted earnings per share have been calculated by dividing ‘net income attributed to the shareholders after zakat and income tax’ amounting to SR 940,163 thousand (2022: SR 805,117 thousand) for the year by the weighted average number of ordinary shares issued and outstanding shares amounting to 150 million shares (2022: 150 million shares) and treasury shares amounting to 495 thousand (2022: 684 thousand shares) at year end. The weighted average number of ordinary shares issued and outstanding at 31 December 2022 have been adjusted for the bonus shares issued during the year ended 31 December 2023. The earnings per share for the year ended 31 December 2022 has been restated on account of adoption of IFRS 17 and IFRS 9.
29. Risk management
The Group has developed and implemented a risk management structure that is designed to identify, assess, control and monitor the risks associated with its business. Adhering to this structure, the Group aims to meet its obligations to policyholders and other customers and creditors, to manage its capital efficiently, and to comply with applicable laws and regulations. The Group’s Risk Committee has overall responsibility for the establishment and oversight of the Group’s risk management framework. The Risk Committee is responsible for defining, installing and monitoring the risk management organisation in order to ensure that its control systems are effective. The Risk Committee approves all risk management policies, as well as the quantitative and qualitative elements of the Group’s risk appetite and tolerance framework.
(a) Insurance risk
The Group provides short-term health insurance contracts in Saudi Arabia. Accordingly, the main insurance risk within the Group is that there are no sufficient reserves available to cover the liabilities associated with the insurance contracts issued. Actual claims may differ from the estimated ultimate claims. The Group seeks to manage this as follows:
Estimate of present value of cash flows and risk adjustment for non-financial risk
- Through close monitoring of the claims’ trend and payments’ pattern to ensure that sufficient reserves are available to cover claim liabilities. The Group also has an external actuary to perform quarterly independent reviews of the reserves adequacy. Estimate of present value of cash flows and risk adjustment for non-financial risk, which are key components of the Group’s insurance contract liabilities are estimated amounts of the outstanding claims, incurred but not reported claims (“IBNR”), claims handling provisions and risk adjustment for non-financial risk. These reserves do not represent exact calculations but rather expectations based on historical claims’ trend (frequency and severity), payments’ pattern, medical inflation, members’ behaviour, seasonality and other factors. The objective of the Company is to ensure that sufficient reserves are available to cover the liabilities associated with the insurance contracts that it issues.
- The Group has a large insurance portfolio resulting in stable claims development patterns which relatively reduces the risk of fluctuations in the estimated ultimate claims. The short-tailed nature of the business is associated with higher consistency of the reserve estimates.
- The Group continually reviews the adequacy of claims reserves by conducting back-testing analysis, assessing the sufficiency of data, monitoring claims backlogs and settlement patterns. In addition, the external actuary runs independent valuation models after due reconciliation with consolidated financial statements to validate reserve adequacy.
Reinsurance
- The Group has a reinsurance arrangement to reduce its exposure through transfer of risk. During the years ended 31 December 2023 and 2022, the Group had quota share reinsurance arrangement for certain group of contracts to reduce its exposure through partial transfer of insurance risk. The reinsurance premium ceded represents a minimal margin of the overall gross premium written. Reinsurance premium ceded reached 1.05% of gross premium written (2022: 0.68%).
- The reinsurers selected met SAMA’s minimum acceptable rating of BBB from a (Reputable credit agency).
- Reinsurance ceded business does not relieve the Group from its obligations to policyholders and as a result the Group remains liable for the portion of outstanding claims reinsured to the extent that the reinsurer fails to meet the obligations under the reinsurance agreements.
Pricing
- The pricing team follows the Group’s underwriting guidelines (approved by the Board of Directors) in setting premiums taking into consideration credible claims experiences for both new business and renewals or medical declarations.
Managing the concentration of insurance risk
- The insurance risk exposure related to policyholders is mainly concentrated in Saudi Arabia. However, through its underwriting strategy, the Group ensures that the portfolio is well diversified and not concentrated within few large clients. Its business is proportionally spread across all regions in the Saudi Arabia, and the Group targets both corporate and retail business. The insurance portfolio is not concentrated in a specific benefit level (diverse medical providers, different deductibles, annual limits and sub-limits.
Process used to decide on assumptions
- Assumptions used in determining estimate of present value of cash flows are based on the best estimate. Ultimate claims are estimated using historical claim trends adjusted for inflation, seasonality, membership growth and any other external or internal factors that may have impact on claim costs. Given the nature of the business, the Group may still be exposed to risk of insufficiency of claim reserves for which actual claim cost may turn out to be higher than the initial estimated ultimate claims.
- The estimation of present value of future cash flows related to incurred but not reported claims (IBNR) is generally subject to a greater degree of uncertainty than the estimation of the present value of future cash flows related to reported claims which are received but not yet settled with the providers. For the case of present value of future cash flows related to reported claims, the Group uses payment information of settled batches with providers to estimate the expected settlement amounts of recently submitted batches, while it uses mainly pre-authorization data to estimate present value of future cash flows related to IBNR. The Group seeks to avoid inadequate reserve levels by adopting established processes in determining claim reserve and using updated information from both claims received and pre-authorization data.
(b) Sensitivity analysis
The Group believes that the claim liabilities under insurance contracts outstanding at year-end are adequate. However, these amounts are not certain and actual payments may differ from the claims liabilities provided in the consolidated Financial Statements. The insurance claim liabilities are sensitive to the various assumptions. It has not been possible to quantify the sensitivity of specific variable such as legislative changes or uncertainty in the estimation process.
2023
SR ’000 |
2022
SR ’000 |
|
Impact on equity, insurance contract liabilities and profit or loss due to change in claims ratio |
||
5% Increase | (792,129) | (645,536) |
5% Decrease | 792,129 | 645,536 |
Impact on equity, insurance contract liabilities and profit or loss due to change in risk adjustment for non-financial risk |
||
5% Increase | (46,812) | (26,945) |
5% Decrease | 20,689 | 23,972 |
The following shows the impact of a reasonable possible change in direct expense ratio on the loss component as at the reporting date. As at 31 December 2023 there was no loss component recognized by the Group.
2023
SR ’000 |
2022
SR ’000 |
|
Impact on equity, insurance contract liabilities and profit or loss due to change in direct expense ratio – loss component* |
||
2% Increase | – | (94,343) |
2% Decrease | – | 60,483 |
* Direct expense ratio is the ratio of sum of directly attributable expenses, acquisition cashflows and
surplus for the period to earned premium.
(c) Market risk
Market risk refers to the potential impact of various market dynamics on the fair value or the expected cash flows of financial instruments. The Group adopts asset allocation guidelines and diversification limits on asset classes, geographies, currencies and securities to ensure that market risk is contained and kept to minimal levels.
The Board of Directors sets the overall risk appetite to a prudent level that does not impact the Group’s operating results. The Management prepares monthly and quarterly reports, highlighting deployment activities and exposure limits to ensure that appropriate monitoring and compliance with the approved guidelines. Management performs continuous assessment of developments in relevant markets to ensure that market risk is monitored and mitigated at the asset class and securities levels.
Market risk comprises three types: interest rate risk, price risk and currency risk.
(i) Interest rate risk
Interest rate risk is the potential change in the fair value of financial instruments and expected cash flows as a result of changes in interest rates. Management constantly monitors developments in global and local interest rates and accordingly allocates the durations of its term deposits and sukuk investments. Investments in term deposits and sukuk instruments have various maturities in order to maximise investment returns while ensuring that liquidity requirements are continuously met. Details of maturities of interest-bearing securities using discounted cashflows as at 31 December are as follows:
2023 (SR ’000) | |||||
Less than
3 months |
3 months to
1 year |
More than
1 year to 3 years |
More than
3 years |
Total | |
Term deposits | 1,363,608 | 2,308,787 | 1,873,512 | 1,677,104 | 7,223,011 |
Financial assets at amortised cost | – | – | – | 587,360 | 587,360 |
Financial assets at fair value – Sukuks | 93,728 | 61,729 | 323,367 | 3,234,341 | 3,713,165 |
1,457,336 | 2,370,516 | 2,196,879 | 5,498,805 | 11,523,536 |
2022 (SR ’000) | |||||
Less than
3 months |
3 months to
1 year |
1 year to
3 years |
More than
3 years |
Total | |
Term deposits | 1,000,000 | 1,945,000 | 2,945,989 | 515,859 | 6,406,848 |
Financial assets at amortised cost | – | – | – | 526,188 | 526,188 |
Financial assets at fair value – Sukuks | 93 ,715 | 142, 359 | 454 ,916 | 1,634,872 | 2,325,862 |
1,093,715 | 2,087,359 | 3,400,905 | 2,676,919 | 9,258,898 |
(ii) Price risk
Price risk is the potential change in the fair value of financial instruments as a result of instrument-specific developments or systemic factors affecting the overall market in which the instrument is being traded.
The total size of investments which are exposed to market price risk is SR 4,246 million (2022: SR 2,852 million). The Group manages this risk conducting thorough due diligence on each instrument prior to investing as well as maintaining exposure limits guidelines to minimise the potential impact of marking to market on the overall portfolio.
The potential impact of a 10% increase or decrease in the market prices of investments carried at fair value through income statement on Group’s profit would be as follows:
Fair value change
% |
Effect on Group’s profit
SR ’000 |
|
2023 | ± 10 | ± 40,997 |
2022 | ± 10 | ± 40,658 |
The potential impact of a 10% increase or decrease in the market prices of investments carried at fair value through other comprehensive income on Group’s total comprehensive income would be as follows:
Fair value change
% |
Effect on Group’s profit
SR ’000 |
|
2023 | ± 10 | ± 377,807 |
2022 | ± 10 | ± 237,453 |
(iii) Currency risk
Currency risk is the potential fluctuation of the value of a financial instrument due to changes in foreign exchange rates. All Group’s transactions are in Saudi Arabian Riyals and US Dollar. Given the peg of Saudi Arabian Riyals and US Dollars, foreign exchange risk is minimal.
(d) Credit risk
Credit risk is the risk that one party to a financial instrument will fail to discharge an obligation and cause the other party to incur a financial loss.
The Group seeks to manage its credit risk with respect to customers by following the Group’s credit control policy and monitoring outstanding receivables on an on-going basis in order to reduce the Group’s exposure to bad debts. The Management estimates specific impairment provisions on a case by case basis. In addition to specific provisions, the Group also makes an additional portfolio provision, estimated on a collective basis, based on the ageing profile of the future premiums cashflow. The Group seeks to limit its credit risk with respect to other counterparties by placing term deposits and investments with reputable financial institutions. The Group enters into reinsurance contracts with recognised, creditworthy third parties (minimum BBB). The maximum exposure to credit risk on reinsurance contract assets is SR 2 million.
The following table shows the maximum exposure to credit risk by class of financial asset:
2023
SR ’000 |
2022
SR ’000 |
|
Cash and cash equivalents | 1,255,896 | 1,287,961 |
Reinsurance contract assets | 74,090 | 28,155 |
Other receivables and accrued income | 396,342 | 354,004 |
Term deposits | 7,223,011 | 6,406,848 |
Financial assets at amortised cost | 587,360 | 526,188 |
Financial assets at fair value | 4,246,757 | 2,852,234 |
Statutory deposit | 149,960 | 149,961 |
Accrued income on statutory deposit | 8,690 | 16,235 |
13,942,106 | 11,621,586 |
The table below provides information regarding the credit risk exposure of the Group by classifying assets according to the Group’s credit rating of counterparties. Investment grade ratings refers to companies with sound credit standing of AAA to BBB- (as per a reputable credit agency) and/or Aaa to Baa3 (as per Moody’s). Ratings below the mentioned threshold are considered sub-investment grade with a higher default risk.
2023 (SR ’000) | ||||
Non-inve stment grade | ||||
Investment
grade |
Not impaired | Impaired | Total | |
Cash and cash equivalents | 1,255,896 | – | – | 1,255,896 |
Reinsurance contract assets | – | 74,090 | – | 74,090 |
Other receivables and accrued income | – | 396,342 | – | 396,342 |
Term deposits | 7,223,011 | – | – | 7,223,011 |
Financial assets at amortised cost | 587,360 | – | – | 587,360 |
Financial assets fair value | 4,246,757 | – | – | 4,246,757 |
Statutory deposit | 149,960 | – | – | 149,960 |
Accrued income on statutory deposit | 8,690 | – | – | 8,690 |
13,471,674 | 470,432 | – | 13,942,106 |
2022 (SR ’000) | ||||
Non-investment grade | ||||
Investment
grade |
Not impaired | Impaired | Total | |
Cash and cash equivalents | 1,287,961 | – | – | 1,287,961 |
Reinsurance contract assets | – | 28,155 | – | 28,155 |
Other receivables and accrued income | – | 354,004 | – | 354,004 |
Term deposits | 6,406,848 | – | – | 6,406,848 |
Financial assets at amortised cost | 526,188 | – | – | 526,188 |
Financial assets at fair value | 2,852,234 | – | – | 2,852,234 |
Statutory deposit | 149,961 | – | – | 149,961 |
Accrued income on statutory deposit | 16,235 | – | – | 16,235 |
11,239,427 | 382,159 | – | 11,621,586 |
The Group does not have any financial asset classified in Stage 2 or 3 as at 31 December 2023 and 2022. The ECL on Stage 1 financial assets is not material.
(e) Liquidity risk
Liquidity risk is the risk that the Group will not be able to meet its operational or financial obligations when they are due. Liquidity requirements are monitored on a monthly basis and management ensures that sufficient liquid funds through premiums received and excess cash are available to meet any commitments as they arise.
The table below summaries the maturity profile of the financial liabilities of the Group based on remaining expected undiscounted contractual obligations:
2023 (SR ’000) | |||
Up to
one year |
More than
one year |
Total | |
Accrued and other liabilities | 734,859 | – | 734,859 |
Insurance contract liabilities | 8,267,196 | – | 8,267,196 |
Lease liability | 35,810 | 149,907 | 185,717 |
Due to related parties | 40,935 | – | 40,935 |
Accrued income payable to Insurance Authority | 8,690 | – | 8,690 |
9,087,490 | 149,907 | 9,237,397 |
2022 (SR ’000) | |||
Up to
one year |
More than
one year |
Total | |
Accrued and other liabilities | 530,715 | – | 530,715 |
Insurance contract liabilities | 6,699,185 | – | 6,699,185 |
Reinsurance contract liabilities | 2,605 | – | 2,605 |
Lease liability | 24,681 | 219,672 | 244,353 |
Accrued income payable to Insurance Authority | 16,235 | – | 16,235 |
7,273,421 | 219,672 | 7,493,093 |
(f) Liquidity profile
All assets excluding financial assets at amortised cost, financial assets at fair value, fixtures, furniture and equipment and right-of-use assets, intangible assets, goodwill, statutory deposit and accrued income on statutory deposit, are expected to be recovered or settled before one year. Term deposits amounting to SR 3,672 million (31 December 2022: SR 2,945 million) mature within one year and the remaining balance have maturities greater than one year.
None of the financial liabilities on the statement of financial position are based on discounted cash flows, with exception of end-of-service benefits and lease liabilities and are all payable on a basis as set out above. There are no differences between contractual and expected maturity of the financial liabilities of the Group.
30. Insurance operations’ surplus payable
2023
SR ’000 |
2022
SR ’000 |
|
Balance at the beginning of the year | 208,021 | 190,060 |
Income attributable to insurance operations during the year | 97,004 | 65,303 |
Surplus paid to policyholders during the year | (44,229) | (47,342) |
Net surplus payable to policyholders | 260,796 | 208,021 |
As a result of the adoption of IFRS 17, net surplus payable to policyholders is reported as part of insurance contract liabilities. Also, income attributable to insurance operations is expensed as part of insurance service expenses.
31. Dividends
During the year ended 31 December 2023, the Group’s Board of Directors proposed to pay dividends for the year ended 31 December 2022 of SR 3.6 per share, totalling SR 540 million (2021: SR 540 million) to its shareholders. The dividends were approved by the shareholders in the Extraordinary General Assembly meeting held on 22 June 2023 and was paid during the year.
32. Insurance service results
2023
SR ’000 |
2022
SR ’000 |
|
Insurance Revenue | ||
Contracts measured under PAA | ||
Insurance revenue | 15,887,715 | 12,873,111 |
Insurance Service Expenses | ||
Incurred claims and other directly attributable expenses | (14,737,829) | (12,094,850) |
Changes that relate to past service – adjustments to the LIC | 428,512 | 18,871 |
Reversal of onerous contract | 61,561 | 448,102 |
Insurance acquisition cash flows amortization | (746,676) | (578,156) |
Total insurance service expenses | (14,994,432) | (12,206,033) |
Insurance service result before reinsurance contracts held | 893,283 | 667,078 |
Allocation of reinsurance premiums | ||
Contracts measured under PAA | ||
Premium ceded on reinsurance contracts held | (151,740) | (73,952) |
Commission earned on reinsurance contracts held | – | – |
Amounts allocated to reinsurance from contracts measured under the PAA |
(151,740) | (73,952) |
Amounts recoverable from reinsurers for incurred claims | ||
Incurred claims and other expenses | 132,817 | 59,888 |
Changes relating to amounts recoverable on incurred claims | (9,323) | (15,386) |
Total amounts recoverable from reinsurance for incurred claims | 123,494 | 44,502 |
Net expense from reinsurance contracts held | (28,246) | (29,450) |
Net insurance Service Result | 865,037 | 637,628 |
33. Claims development table
The following tables show the estimates of cumulative incurred claims, including both claims reported and IBNR for each successive accident year at each reporting date, together with cumulative payments to date. As required by IFRS 17, in setting claims provisions, the Company gives consideration to the probability and magnitude of future experience being more adverse than assumed which is reflected in the risk adjustment.
In general, the uncertainty associated with the ultimate cost of settling claims is greatest when the claim is at an early stage of development. As claims develop, the ultimate cost of claims becomes more certain.
The Company aims to maintain adequate reserves in respect of its insurance business in order to protect against adverse future claims experience and developments. Claims triangulation analysis is by accident years, spanning a number of financial years.
2023 Accident year | 2020 and
earlier SR ’000 |
2021
SR ’000 |
2022
SR ’000 |
2023
SR ’000 |
Total
SR ’000 |
Undiscounted liabilities for incurred claims, gross of reinsurance: |
|||||
At end of accident year | 46,940,903 | 9,775,177 | 11,314,093 | 13,529,148 | 81,559,321 |
1 year later | 46,247,258 | 9,355,664 | 10,938,600 | – | 66,541,522 |
2 years later | 46,291,114 | 9,371,807 | – | – | 55,662,921 |
3 years later | 46,308,390 | – | – | – | 46,308,390 |
Current estimate of ultimate claims | 46,308,390 | 9,371,807 | 10,938,600 | 13,529,148 | 80,147,945 |
Ultimate payments to date | 46,279,621 | 9,324,463 | 10,801,211 | 10,702,450 | 77,107,745 |
Liability recognised in the consolidated statement of financial position | 28,769 | 47,344 | 137,389 | 2,826,698 | 3,040,200 |
Other related reserves | 174,026 | ||||
Loss component | – | ||||
Balance at 31 December | 3,214,226 |
2022 Accident year | 2019 and
earlier SR ’000 |
2020
SR ’000 |
2021
SR ’000 |
2022
SR ’000 |
Total
SR ’000 |
Undiscounted liabilities for incurred claims, gross of reinsurance: |
|||||
At end of accident year | 40,036,189 | 8,742,056 | 9,775,177 | 11,314,093 | 69,867,515 |
1 year later | 40,035,152 | 8,048,412 | 9,355,664 | – | 57,439,228 |
2 years later | 40,041,050 | 8,092,267 | – | – | 48,133,317 |
3 years later | 40,003,901 | – | – | – | 40,003,901 |
Current estimate of ultimate claims | 40,003,901 | 8,092,267 | 9,355,664 | 11,314,093 | 68,765,925 |
Ultimate payments to date | 39,993,268 | 8,078,148 | 9,288,011 | 9,008,116 | 66,367,543 |
Liability recognised in the consolidated statement of financial position |
10,633 | 14,119 | 67,653 | 2,305,977 | 2,398,382 |
Other related reserves | 145,602 | ||||
Loss component | 61,561 | ||||
Balance at 31 December | 2,605,545 |
2023 Accident year | 2020 and
earlier SR ’000 |
2021
SR ’000 |
2022
SR ’000 |
2023
SR ’000 |
Total
SR ’000 |
Undiscounted liabilities for incurred claims, net of reinsurance |
|||||
At end of accident year | 46,892,338 | 9,708,417 | 11,253,658 | 13,405,271 | 81,259,684 |
1 year later | 46,196,203 | 9,295,165 | 10,878,036 | – | 66,369,404 |
2 years later | 46,244,431 | 9,309,698 | – | – | 55,554,129 |
3 years later | 46,261,579 | – | – | – | 46,261,579 |
Current estimate of ultimate claims | 46,261,579 | 9,309,698 | 10,878,036 | 13,405,271 | 79,854,584 |
Ultimate payments to date | 46,232,842 | 9,263,916 | 10,749,970 | 10,618,143 | 76,864,871 |
Liability recognised in the consolidated statement of financial position |
28,737 | 45,782 | 128,066 | 2,787,128 | 2,989,713 |
Other related reserves | 171,810 | ||||
Loss component | – | ||||
Balance at 31 December | 3,161,523 |
2022 Accident year | 2019 and
earlier SR ’000 |
2020
SR ’000 |
2021
SR ’000 |
2022
SR ’000 |
Total
SR ’000 |
Undiscounted liabilities for incurred claims, net of reinsurance |
|||||
At end of accident year | 39,962,229 | 8,693,491 | 9,708,417 | 11,253,658 | 69,617,795 |
1 year later | 39,959,410 | 7,997,356 | 9,295,165 | – | 57,251,931 |
2 years later | 39,961,351 | 8,045,584 | – | – | 48,006,935 |
3 years later | 39,927,912 | – | – | – | 39,927,912 |
Current estimate of ultimate claims | 39,927,912 | 8,045,584 | 9,295,165 | 11,253,658 | 68,522,319 |
Ultimate payments to date | 39,917,279 | 8,031,478 | 9,227,799 | 8,967,204 | 66,143,760 |
Liability recognised in the consolidated statement of financial position | 10,633 | 14,106 | 67,366 | 2,286,454 | 2,378,559 |
Other related reserves | 144,700 | ||||
Loss component | 61,561 | ||||
Balance at 31 December | 2,584,820 |
34. Approval of consolidated financial statements
The consolidated Financial Statements have been approved by the Board of Directors, on 17 Rajab 1445H corresponding to 29 January 2024.
35. Supplementary information
Consolidated statement of financial position
2023 | 2022 | |||||
Insurance
operations SR ’000 |
Sh
areholders’
operations SR ’000 |
Total
SR ’000 |
Insurance
operations SR ’000 |
Shareholders’
operations SR ’000 |
Total
SR ’000 |
|
Total assets | 9,009,617 | 5,428,734 | 14,438,351 | 7,104,401 | 5,010,530 | 12,114,931 |
Total liabilities | 8,990,970 | 771,852 | 9,762,822 | 7,125,461 | 788,581 | 7,914,042 |
Total equity | 18,647 | 4,656,882 | 4,675,529 | (21,060) | 4,221,949 | 4,200,889 |
Consolidated statement of income
2023 | 2022 | |||||
Insurance
operations SR ’000 |
Sh
areholders’
operations SR ’000 |
Total
SR ’000 |
Insurance
operations SR ’000 |
Shareholders’
operations SR ’000 |
Total
SR ’000 |
|
Insurance revenue | 15,887,715 | – | 15,887,715 | 12,873,111 | – | 12,873,111 |
Insurance service expense | (14,994,432) | – | (14,994,432) | (12,206,033) | – | (12,206,033) |
Net expenses from reinsurance contracts held | (28,246) | – | (28,246) | (29,450) | – | (29,450) |
Net insurance service result | 865,037 | – | 865,037 | 637,628 | – | 637,628 |
Investment income on financial assets at amortised cost | 233,984 | 116,652 | 350,636 | 103,241 | 63,956 | 167,197 |
Investment income on financial assets at fair value | 72,629 | 90,796 | 163,425 | 51,656 | 334,966 | 386,622 |
Net impairment loss on financial assets | (656) | (129) | (785) | (1,028) | (657) | (1,685) |
Net insurance and investment results | 1,170,994 | 207,319 | 1,378,313 | 791,497 | 398,265 | 1,189,762 |
Other operating expenses | (297,956) | (18,857) | (316,813) | (231,628) | (15,226) | (246,854) |
Other revenue | – | 92,065 | 92,065 | – | 42,633 | 42,633 |
Other cost | – | (36,886) | (36,886) | – | (16,378) | (16,378) |
Income attributed to the shareholders before, zakat and income tax | 873,038 | 243,641 | 1,116,679 | 559,869 | 409,294 | 969,163 |
Transfer of surplus to shareholders (after deducting 10% policyholder surplus) | (776,034) | 776,034 | – | (494,566) | 494,566 | – |
Income attributed to the shareholders before zakat and income tax | 97,004 | 1,019,675 | 1,116,679 | 65,303 | 903,860 | 969,163 |
Zakat charge | – | (80,237) | (80,237) | – | (72,938) | (72,938) |
Income tax charge | – | (96,279) | (96,279) | – | (91,108) | (91,108) |
Net income attributed to the shareholders after zakat and income tax | 97,004 | 843,159 | 940,163 | 65,303 | 739,814 | 805,117 |
Total other comprehensive Income/(loss) | 39,707 | 27,441 | 67,148 | (30,894) | (247,625) | (278,519) |
Total comprehensive income for the year | 136,711 | 870,600 | 1,007,311 | 34,409 | 492,189 | 526,598 |
Consolidated statement of cash flows
2023 | 2022 | |||||
Insurance
operations SR ’000 |
Sh
areholders’
operations SR ’000 |
Total
SR ’000 |
Insurance
operations SR ’000 |
Shareholders’
operations SR ’000 |
Total
SR ’000 |
|
Net income attributed to shareholders before zakat and income tax | – | 1,116,679 | 1,116,679 | – | 969,163 | 969,163 |
Net cash generated from operating activities | 1,463,993 | 813,281 | 2,277,274 | 1,025,059 | 680,246 | 1,705,305 |
Net cash used in investing activities | (1,215,765) | (510,058) | (1,725,823) | (1,306,485) | 526,346 | (780,139) |
Net cash used in financing activities | – | (583,516) | (583,516) | – | (597,790) | (597,790) |
Net change in cash and cash equivalents | 248,228 | (280,293) | (32,065) | (281,426) | 608,802 | 327,376 |
Cash and cash equivalents at beginning of the year | 649,097 | 638,864 | 1,287,961 | 930,523 | 30,062 | 960,585 |
Cash and cash equivalents at end of the year | 897,325 | 358,571 | 1,255,896 | 649,097 | 638,864 | 1,287,961 |